WO2024257850A1 - Système et programme d'injection mixte - Google Patents

Système et programme d'injection mixte Download PDF

Info

Publication number
WO2024257850A1
WO2024257850A1 PCT/JP2024/021646 JP2024021646W WO2024257850A1 WO 2024257850 A1 WO2024257850 A1 WO 2024257850A1 JP 2024021646 W JP2024021646 W JP 2024021646W WO 2024257850 A1 WO2024257850 A1 WO 2024257850A1
Authority
WO
WIPO (PCT)
Prior art keywords
infusion
container
unit
drug
control unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/JP2024/021646
Other languages
English (en)
Japanese (ja)
Inventor
純也 北川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyama Manufacturing Co Ltd
Original Assignee
Yuyama Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyama Manufacturing Co Ltd filed Critical Yuyama Manufacturing Co Ltd
Priority to JP2025528006A priority Critical patent/JPWO2024257850A1/ja
Publication of WO2024257850A1 publication Critical patent/WO2024257850A1/fr
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Definitions

  • the present invention relates to a drug mixing system that assists in the mixing of drugs.
  • the co-injection process in which a drug contained in a drug container such as a vial is drawn up with a syringe and the drug in the syringe is injected into an infusion container such as an infusion bag, may be performed by a user such as a pharmacist.
  • co-injection devices that can automatically perform the co-injection process are also known (see, for example, Patent Document 1).
  • multiple preparation methods may be used when performing the mixing processing, such as manual preparation in which the user performs the mixing processing, and machine preparation in which the mixing processing is automatically performed by a mixing device.
  • the object of the present invention is to provide a co-injection system that can assist in the selection of a preparation method appropriate to the situation based on preparation data.
  • the co-infusion system includes a selection processing unit that selects a preparation method for the co-infusion process based on each of the preparation data based on a specific time at which a specific process is executed to identify one or more preparation data to be used for the co-infusion process of injecting a drug from a drug container into an infusion container and the administration time of the drug corresponding to each of the preparation data.
  • the program of the present invention is a program for causing a processor to execute a selection step of selecting a preparation method for a mixing process based on each of the preparation data, based on a specific time at which a specific process is executed to identify one or more preparation data that are to be subjected to a mixing process for injecting a drug from a drug container into an infusion container, and on the administration time of the drug corresponding to each of the preparation data.
  • the present invention provides a co-injection system that can assist in the selection of a preparation method appropriate to the situation for the preparation data.
  • FIG. 1 is a perspective view showing an example of the overall configuration of a co-infusion device according to the present embodiment.
  • FIG. 2 is a perspective view showing an example of a schematic internal configuration of the co-infusion device when the co-infusion device is viewed from the front.
  • FIG. 3 is a perspective view showing an example of a schematic internal configuration of the co-infusion device when the co-infusion device is viewed from the rear.
  • FIG. 4 is a block diagram showing an example of the overall configuration of a co-infusion device.
  • FIG. 5 is a perspective view showing an example of the configuration of the co-infusion unit.
  • FIG. 6 is a front view showing an example of a schematic configuration of the co-infusion unit.
  • FIG. 1 is a perspective view showing an example of the overall configuration of a co-infusion device according to the present embodiment.
  • FIG. 2 is a perspective view showing an example of a schematic internal configuration of the co-infusion device when the co-infusion device is viewed from the
  • FIG. 7 is a diagram for explaining adjustment of the needle tip position of the syringe.
  • FIG. 8 is a diagram illustrating an example of the configuration of the second transport unit.
  • FIG. 9 is a diagram for explaining the reading position of the first information.
  • FIG. 10 is a perspective view showing an example of the overall configuration of a syringe shelf and a medicine container shelf.
  • FIG. 11 is a diagram showing an example of the configuration of one syringe shelf and one medicine container shelf when viewed from the first transporting unit side, and a diagram for explaining the medicine container shelf.
  • FIG. 12 is a flowchart showing an example of a process flow of the control unit when the control unit receives an instruction to collect a medicine container.
  • FIG. 12 is a flowchart showing an example of a process flow of the control unit when the control unit receives an instruction to collect a medicine container.
  • FIG. 13 is a perspective view showing an example of the configuration of an infusion shelf.
  • FIG. 14 is a diagram showing an example of a specific configuration of the pushing portion.
  • FIG. 15 is a side view showing an example of the pushing transport section.
  • FIG. 16 is a perspective view showing an example of the overall configuration of the printing and inspection unit.
  • FIG. 17 is a perspective view of the printing and inspection unit as seen from the rear.
  • FIG. 18 is a perspective view showing an example of the internal configuration of the printing and inspection unit.
  • FIG. 19 is a diagram for explaining an example of an operation from reading the first information to attaching the second label.
  • FIG. 20 shows an example of an infusion container having a first label attached to its first surface, and an example of an infusion container having a second label attached to its second surface.
  • FIG. 20 shows an example of an infusion container having a first label attached to its first surface, and an example of an infusion container having a second label attached to its second surface.
  • FIG. 21 is a front view showing an example of an infusion receiving shelf.
  • FIG. 22 is a side view showing an example of an infusion receiving shelf.
  • FIG. 23 is a diagram showing an example of the shape of the rail portion.
  • FIG. 24 is a diagram for explaining the shutter.
  • FIG. 25 is a block diagram showing the configuration of a co-injection system.
  • FIG. 26 is a flowchart showing an example of a data output process.
  • FIG. 27 is a diagram showing an example of grouping of preparation data in the co-infusion system.
  • FIG. 28 is a diagram showing an example of a display screen in the co-injection system.
  • FIG. 29 is a diagram showing an example of a transport tray used in the co-infusion system.
  • FIG. 30 is a diagram showing an example of a form printed by the co-infusion system.
  • FIG. 31 is a flowchart showing an example of the mixed injection control process.
  • FIG. 32 is a flowchart showing an example of the mixed injection cancellation process.
  • FIG. 33 is a flowchart showing an example of a transfer control process.
  • FIG. 34 is a diagram showing an example of a label printed by the co-infusion system.
  • FIG. 35 is a flowchart showing an example of the medicine dispensing process.
  • FIG. 34 is a diagram showing an example of an injection prescription printed by the co-injection system.
  • FIG. 37 is a flowchart showing an example of the tray collation process.
  • FIG. 38 is a diagram showing an example of a display screen in the co-injection system.
  • FIG. 39 is a diagram showing an example of a display screen in the co-injection system.
  • FIG. 40 is a flowchart showing an example of a preparation method selection process.
  • the X-axis and Y-axis are two mutually perpendicular axes in a horizontal plane (the contact surface of the co-infusion device 1).
  • the positive X-axis direction is sometimes referred to as the rightward direction, and the negative X-axis direction is sometimes referred to as the leftward direction.
  • the positive Y-axis direction is sometimes referred to as the farther direction or rearward direction, and the negative Y-axis direction is sometimes referred to as the nearer direction or forward direction.
  • the Z-axis is an axis that extends vertically to the XY plane, and the positive Z-axis direction is sometimes referred to as the upward direction, and the negative Z-axis direction is sometimes referred to as the downward direction.
  • FIG. 1 is a perspective view showing an example of the overall configuration of a co-infusion device 1.
  • the co-infusion device 1 includes a syringe shelf 10, a medicine container shelf 20, an infusion shelf 30, a printing and inspection unit 50, an infusion receiving shelf 60, a trash can section 70, and a touch panel 80.
  • the co-infusion device 1 is a device that executes a co-infusion process (co-infusion operation) that uses a drug indicated in data related to preparation and administration (hereinafter referred to as preparation data), a syringe, and an infusion to mix the drug and the infusion. More specifically, the co-infusion device 1 executes a co-infusion process that uses a syringe to aspirate the drug indicated in the preparation data from a drug container such as a vial in which the drug is contained, and injects the drug into an infusion container such as an infusion bag in which the infusion is contained.
  • the infusion used in the co-infusion process may be, for example, saline (physiological saline) or a liquid containing glucose.
  • the syringe, drug container, infusion container, etc. used in the co-infusion process may be collectively referred to as equipment.
  • co-infusion processes include a process of aspirating a drug from a drug container using a syringe and injecting it into another drug container, or a process of aspirating a liquid from an infusion container using a syringe and injecting it into the drug container.
  • a drug container contains a solid drug (powder, etc.)
  • the co-infusion device 1 uses a syringe to aspirate the liquid from the infusion container and injects the liquid into the drug container. This makes it possible to turn the solid drug into a liquid in the drug container.
  • the co-infusion device 1 then uses a syringe to inject the liquid drug into the infusion container.
  • the user can load a syringe, drug container, and infusion container into the co-injection device 1 by, for example, opening and closing a door.
  • the air purifying unit described below keeps the inside of the co-injection device 1 clean, reducing the possibility of contamination of the drug and infusion during the co-injection process.
  • the inside of the co-injection device 1 is kept at positive pressure.
  • the co-injection device 1 handles drugs such as anticancer drugs, the inside of the co-injection device 1 is kept at negative pressure.
  • the preparation data is data required by the control unit 140 (see FIG. 4) of the co-infusion device 1 to perform the co-infusion process and the printing process of the second label (see reference numeral 1062 in FIG. 20), and is generated based on the prescription data. Specifically, the preparation data is generated based on the prescription data by the higher-level system 2 described below, and input from the higher-level system 2 to the co-infusion device 1. The preparation data may be generated by the control unit 140 of the co-infusion device 1.
  • the control unit 140 of the co-infusion device 1 may convert the preparation data into working preparation data for executing the co-infusion process based on the preparation data in the co-infusion device 1 according to preset conversion conditions, and then the co-infusion process may be executed.
  • the control unit 140 automatically issues the plurality of preparation data received from the upper system 2 and sets them as the target of execution, so that the mixing process based on each of the preparation data is executed in sequence. Therefore, the preparation data becomes a mixing instruction (injection instruction) for executing the mixing process in the mixing device 1.
  • the mixing device 1 reserves the execution of the mixing process based on the preparation data, and when the mixing device 1 issues the preparation data to be executed, or when a preset timing arrives, the preparation data is issued and the mixing process based on the preparation data is executed. In other words, even if the input of the preparation data to the mixing device 1 functions as a mixing instruction, the mixing instruction does not have to instruct the mixing process based on the preparation data to be executed immediately. Furthermore, as another embodiment, the mixing instruction may be transmitted from the upper system 2 of the mixing device 1 to the mixing device 1 for each mixing process.
  • the control unit 140 requests the upper system 2 to transmit preparation data for the co-infusion device 1 to execute the next co-infusion process.
  • the control unit 140 receives the preparation data, it starts the next co-infusion process.
  • the preparation data includes, for example, information indicating the type of drug used in the mixed injection process, the prescribed amount of the drug, information indicating the type of syringe, information indicating the type of infusion (infusion type information), and information indicating the amount of infusion drawn from the infusion container.
  • the preparation data also includes information on the number of pieces of equipment, such as drug containers, infusion containers, and syringes, required for the mixed injection process based on the preparation data. Note that, as another embodiment, even if the preparation data does not include information on the number of pieces of equipment, if the preparation data includes the amount of drug or infusion used to identify the information on the number of pieces of equipment, the control unit 140 may identify the number of pieces of equipment based on the amount used.
  • the preparation data includes information about the infusion container into which the medication is to be injected, as information to be printed on the second label LA12.
  • This information includes prescription attribute information, prescription detail information, an order number indicating the order in which the prescription was received, and infusion type information (e.g., infusion name), etc.
  • the prescription attribute information, prescription detail information, an order number indicating the order in which the prescription was received, and infusion type information, etc., are information included in the prescription data that is referenced to generate the preparation data.
  • the prescription attribute information includes information indicating the name and patient ID of the patient to whom the drug has been prescribed (an example of patient identification information for identifying the patient), the name of the ward and room in which the patient is hospitalized, the name of the medical professional (an example of a person in charge) who will administer the mixed drug to the patient, and the name of the department to which the medical professional belongs.
  • the prescription attribute information may also include physical information such as the patient's weight, height, or body surface area. The patient's physical information is used, for example, for the purpose of calculating a standard dosage that indicates the amount of drug to be administered per body surface area of the patient.
  • the prescription details information includes information indicating the prescription category (time of administration, such as regular, temporary, emergency, or regular medicine), Rp (recipe) number, infusion technique, route, drug name (an example of drug identification information indicating the type of drug), usage, dosage, administration time, comments, etc.
  • the prescription category indicates the category of prescription data, and the prescription category includes, for example, the administration time of regular, emergency, or regular medicine.
  • the Rp is information on the application unit including the drug name, usage, dosage, etc., and one prescription data may include one or more Rp.
  • one infusion container is generated as the deliverable for each Rp.
  • one preparation data includes data for executing the mixed injection process for one Rp.
  • the route is information indicating the destination of the liquid in the infusion container into which the drug is injected (e.g., peripheral vein or peripheral internal jugular).
  • the administration time is information indicating the implementation timing, such as the date (hereinafter sometimes referred to as the administration date) and time when the drug in the infusion container, which is the result of the mixing process by the mixing device 1, is administered to the patient, and is an example of the administration time of the drug according to the present invention.
  • the prescription details information also includes information to the effect that if the drug is a drug for which early administration after mixing is recommended due to the possibility of a change in the composition.
  • the information regarding the infusion container into which the drug is to be injected may include at least the name of the drug, the patient's name, the name of the hospital room, and information indicating the date of the co-infusion.
  • the date of the co-infusion is information that is recorded as the date on which the co-infusion device 1 actually performs the co-infusion process (the date on which the prescribed drug is injected into the infusion container).
  • the syringe shelf 10 is an equipment storage shelf capable of storing the syringes loaded in the co-injection device 1.
  • the co-injection device 1 is provided with two upper and lower syringe shelves 10 as shown in FIG. 1.
  • the syringe shelf 10 is provided with a syringe side door 16. A user can hold a syringe on the syringe shelf 10 by opening and closing the syringe side door 16.
  • the types of syringes stored on each of the upper and lower syringe shelves 10 are predetermined, and in the co-injection process, a syringe stored on one of the syringe shelves 10 is used depending on the type of syringe specified by the preparation data.
  • the drug container shelf 20 is an equipment storage shelf capable of storing drug containers filled in the co-infusion device 1.
  • the co-infusion device 1 is provided with two infusion shelves 30, one above the other, as shown in FIG. 1.
  • the drug container shelf 20 is provided with a drug container side door 27. A user can hold a drug container on the drug container shelf 20 by opening and closing the drug container side door 27.
  • the infusion shelf 30 is an infusion storage shelf capable of storing infusion containers filled in the co-infusion device 1.
  • the infusion shelf 30 is provided with an infusion side door 34. The user can hold the infusion container on the infusion shelf 30 by opening and closing the infusion side door 34.
  • the syringe side door 16, the drug container side door 27, and the infusion side door 34 are doors that can block the user's access to the syringe shelf 10, the drug container shelf 20, and the infusion shelf 30, respectively.
  • the control unit 140 described below controls the syringe side door 16, the drug container side door 27, and the infusion side door 34 so that only one of them is in an unlocked state.
  • the printing and inspection unit 50 is a unit that prints (records) preset second information (an example of recorded information) related to preparation data on a second label LA12 (an example of a recording medium) attached to the infusion container and affixes it to the infusion container before or after drug injection, and is an example of a first recording section according to the present invention.
  • the printing and inspection unit 50 may record the second information on an IC tag or the like affixed to the infusion container, or may record it directly on the infusion container.
  • the printing and inspection unit 50 may print an inappropriate information label (described below) and affix it to the infusion container after drug injection.
  • the printing and inspection unit 50 is also a unit that weighs the infusion container before and after drug injection.
  • the infusion receiving shelf 60 is a unit that receives infusion containers with the second label LA12 affixed thereto after drug injection.
  • the infusion receiving shelf 60 is provided with an infusion receiving door 61.
  • the trash can section 70 is a box that receives used syringes.
  • the touch panel 80 has the functions of an operation section that receives various operations by the user, and a display section that displays various information. Note that, instead of the touch panel 80, the operation section and the display section may be provided as separate members. Also, together with or instead of the display section, a presentation section (e.g., a speaker) that presents various information may be provided.
  • FIG. 2 is a perspective view showing an example of a schematic internal configuration of the co-infusion device 1 when viewed from the front (near side).
  • Fig. 3 is a perspective view showing an example of a schematic internal configuration of the co-infusion device 1 when viewed from the rear (rear direction).
  • the co-injection device 1 includes the above-mentioned syringe shelf 10, drug container shelf 20, infusion shelf 30, printing and inspection unit 50, infusion receiving shelf 60, and trash can section 70, as well as a co-injection unit 40 (an example of a co-injection processing section), a first transport section 110, a second transport section 120, and an air purifying section 130.
  • a co-injection unit 40 an example of a co-injection processing section
  • the syringe used in the co-injection device 1 may be referred to as syringe 501, the drug container as drug container 502, and the infusion container as infusion container 503.
  • the mixing unit 40 functions as an injection section that injects medicine into the infusion container 503 that contains the infusion liquid.
  • the mixing unit 40 injects medicine into the infusion container 503, the medicine is mixed with the infusion liquid in the infusion container 503.
  • the mixing unit 40 also functions as a member that extracts the infusion liquid from the infusion container 503.
  • the mixing unit 40 can inject the infusion liquid into the medicine container 502 by extracting the infusion liquid from the infusion container 503. This allows the solid medicine contained in the medicine container 502 to be liquidized.
  • the mixing unit 40 is located between the syringe shelf 10 and the medicine container shelf 20 and the infusion shelf 30 and the infusion receiving shelf 60.
  • the mixing unit 40 injects 10 ml of infusion fluid from the infusion fluid container 503 into two medicine containers 502 each containing 0.5 g of solid medicine, converts the medicine into a liquid form, and then injects the liquid medicine into the infusion fluid container 503.
  • the mixing unit 40 first aspirates 20 ml of infusion fluid used to dissolve the medicine in the two medicine containers 502 from the infusion fluid container 503. Then, the mixing unit 40 pierces the first medicine container 502 with the injection needle of the syringe 501 into the medicine container 502 with the mouth of the first medicine container 502 facing upward, downward, or horizontally.
  • the mixing unit 40 injects only 10 ml of the liquid in the syringe 501 from the syringe 501 into the first medicine container 502, and then aspirates 10.5 ml of the liquid medicine from the medicine container 502. This series of injection and suction operations is repeated a preset number of times. As a result, the solid medicine in the first medicine container 502 is sucked into the syringe 501 as a liquid medicine. Next, the mixing unit 40 pierces the second medicine container 502 with the injection needle of the syringe 501 into the mouth of the medicine container 502 in the same manner as the first one.
  • the mixing unit 40 repeats a series of injection and suction operations, in which only 10 ml of the liquid in the syringe 501 is injected from the syringe 501 into the second medicine container 502, and then 10.5 ml of the liquid medicine is sucked from the medicine container 502, a preset number of times.
  • the solid medicine in the second medicine container 502 is also sucked into the syringe 501 as a liquid medicine. That is, 20 ml of the liquid medicine in which 0.5 g of the medicine in the first medicine container 502 is dissolved is used to dissolve the medicine in the second medicine container 502.
  • the mixing unit 40 injects the liquid medicine in the syringe 501 into the infusion container 503 together.
  • This makes it possible to shorten the time required for the mixed injection process compared to when the liquid medicine is injected into the infusion container 503 by performing the injection and suction operation individually for each medicine container 502, i.e., when it is necessary to suction the infusion from the infusion container 503 and inject the medicine into the infusion container 503 the same number of times as the number of medicine containers 502.
  • 20 ml of the liquid in the syringe 501 may be injected only in the injection and suction operation of the second medicine container 502, or 20 ml of the liquid in the syringe 501 may be injected in the injection and suction operations of both the first medicine container 502 and the second medicine container 502.
  • the first transport unit 110 functions as a container transport unit that transports the syringe 501 indicated in the preparation data from the syringe shelf 10 to the mixing unit 40, or transports the drug container 502 containing the drug indicated in the preparation data from the drug container shelf 20 to the mixing unit 40.
  • the first transport unit 110 transports the syringe 501 stored on the syringe shelf 10 and the drug container 502 stored on the drug container shelf 20 to the mixing unit 40.
  • the first transport unit 110 grasps the upper part of the body of the syringe 501 stored on the syringe shelf 10 and delivers the syringe 501 to the mixing unit 40.
  • the first transport unit 110 grasps the neck of the drug container 502 stored on the drug container shelf 20 and delivers the drug container 502 to the mixing unit 40.
  • the first transport unit 110 also transports the syringe 501 stored in the syringe shelf 10 to a cap attachment/detachment unit (not shown) before transporting the syringe 501 to the co-injection unit 40. This allows the first transport unit 110 to remove the needle cap attached to the needle of the syringe 501, and transport the syringe 501 with the needle cap removed to the co-injection unit 40.
  • the first transport unit 110 also transports the syringe 501 and drug container 502 after the co-injection process (the syringe 501 and drug container 502 that are no longer needed) to the trash can unit 70.
  • the first transport unit 110 is a transport unit that transports the syringe 501 and the drug container 502 and is shared by both the syringe 501 and the drug container 502, but is not limited to this.
  • a transport unit dedicated to transporting the syringe 501 and a transport unit dedicated to transporting the drug container 502 may be provided.
  • the second transport unit 120 functions as an infusion container transport unit that transports the infusion container 503 indicated in the preparation data between the infusion shelf 30, the mixing unit 40, the printing and inspection unit 50, and the infusion receiving shelf 60.
  • the infusion shelf 30 arranged in the upper tier stores infusion containers 503 in an arrangement of five lanes aligned in the left-right direction (X-axis direction). Meanwhile, the infusion shelf 30 arranged in the lower tier stores infusion containers 503 in an arrangement of four lanes aligned in the left-right direction (X-axis direction).
  • Each infusion shelf 30 can store a predetermined number of infusion containers 503 in the front-back direction (Y-axis direction) of each lane, depending on the type of infusion container 503.
  • the type of infusion container 503 stored in each lane is predetermined, and in the co-infusion process, the infusion container 503 stored in one of the lanes of the infusion shelf 30 is used depending on the type of infusion container 503 specified in the preparation data.
  • the second transport unit 120 transports the infusion container 503 to the mixing unit 40.
  • the second transport unit 120 transports the infusion container 503 stored on the infusion shelf 30 to the mixing unit 40.
  • the second transport unit 120 adsorbs the body of the infusion container 503 stored on the infusion shelf 30 and hands it over to the mixing unit 40.
  • the second transport unit 120 also transports the infusion container 503 between the mixing unit 40 and the printing and inspection unit 50.
  • the second transport unit 120 picks up the body of the infusion container 503 after the drug has been injected and transports it to the printing and inspection unit 50.
  • the second transport unit 120 also functions as a transfer unit that transfers the infusion container 503 into which the drug has been injected by the mixing unit 40 to the infusion receiving shelf 60.
  • the second transport unit 120 adsorbs the body of the infusion container 503 after drug injection to which second information different from the first information has been attached by the printing/inspection unit 50 (the second label LA12, or the second label LA12 and the inappropriate information label have been affixed), and transfers it to the infusion receiving shelf 60. Details of the first information and the second information will be described later.
  • the air purification unit 130 purifies and exhausts the air inside the co-injection device 1. In this embodiment, it is provided at the top of the co-injection device 1. The air purified by the air purification unit 130 flows from the top to the bottom of the co-injection device 1.
  • the air purification unit 130 has, for example, a HEPA (High Efficiency Particulate Air) filter.
  • each component in the co-infusion device 1 is not limited to the arrangement described above.
  • the medicine container shelf 20 may be provided on the upper level of the syringe shelf 10.
  • the syringe shelf 10 and the medicine container shelf 20 may be provided on the upper level of the infusion shelf 30, the infusion receiving shelf 60, and the printing and inspection unit 50.
  • the syringe shelf 10, the medicine container shelf 20, and the infusion shelf 30 are each provided on multiple levels, but each may be provided on one level.
  • the infusion receiving shelf 60 is provided on one level, but each may be provided on multiple levels.
  • the printing and inspection unit 50 and the infusion receiving shelf 60 may be provided on the opposite level.
  • the arrangement of each component in the co-infusion device 1 may be determined taking into consideration the convenience of the user and the ease of manufacture.
  • a syringe side door 16 and/or a drug container side door 27 may be provided on the side of the co-infusion device 1 (FIG. 2, right side of the page).
  • one syringe 501 and one drug container 502 are loaded from the front side of the co-infusion device 1.
  • multiple syringes 501 or multiple drug containers 502 can be loaded from the side side of the co-infusion device 1.
  • an infusion side door 34 may be provided on the side side of the co-infusion device 1 (FIG. 2, left side of the page).
  • the co-infusion device 1 may also be configured as a co-infusion device that performs co-infusion processing using one or more robot arms, as disclosed in, for example, JP 2022-40295 A.
  • the co-infusion device 1 includes a control unit 140 and a storage unit 200. Note that FIG. 4 illustrates the main hardware components of the co-infusion device 1 that can be controlled by the control unit 140.
  • the control unit 140 controls the overall operation of the co-injection device 1 based on the preparation data, and is an example of a co-injection control device according to the present invention.
  • the control unit 140 includes, for example, a syringe transport control unit 141, a drug container transport control unit 142, a first transport control unit 143, a co-injection unit control unit 144, a second transport control unit 145, a pushing control unit 147, a printing and inspection unit control unit 148, and a touch panel control unit 149.
  • the syringe transport control unit 141 controls the operation of the components related to the transport of the syringe 501 in the syringe shelf 10.
  • the drug container transport control unit 142 controls the operation of the components related to the transport of the drug container 502 in the drug container shelf 20.
  • the co-injection unit control unit 144 controls the operation of the components provided in the co-injection unit 40.
  • the first transport control unit 143 controls the operation of the components included in the first transport unit 110.
  • the first transport control unit 143 controls the movement of the first transport unit 110 between, for example, the syringe shelf 10, the drug container shelf 20, the mixing unit 40, the trash can section 70, and the cap attachment/detachment section (not shown).
  • the second transport control unit 145 controls the operation of the components included in the second transport unit 120.
  • the second transport control unit 145 controls the movement of the second transport unit 120 between, for example, the infusion shelf 30, the mixing unit 40, the printing/inspection unit 50, and the infusion receiving shelf 60.
  • the push-in control unit 147 controls the operation of the components related to the transportation of the infusion container 503 in the infusion shelf 30.
  • the printing and inspection unit control unit 148 controls the operation of the components provided in the printing and inspection unit 50.
  • the touch panel control unit 149 controls the touch panel 80.
  • the storage unit 200 stores data for the control unit 140 to perform the mixing process and the printing process.
  • the storage unit 200 stores, for example, preparation data.
  • the storage unit 200 also stores a pharmaceutical master.
  • the pharmaceutical master includes information such as a pharmaceutical code, a pharmaceutical name, a JAN code (or RSS), a medicine bottle code, a classification (dosage form: powdered medicine (powdered medicine), a tablet, a liquid medicine, an external medicine, etc.), a specific gravity, a viscosity, a medicine type (ordinary medicine, anticancer drug, poison, narcotic drug, powerful drug, antipsychotic drug, therapeutic drug, etc.), a compounding change, an excipient drug, a caution, a type of a pharmaceutical container (ampule, pharmaceutical container bottle), a pharmaceutical capacity (predetermined amount) per pharmaceutical container, a container shape information of the pharmaceutical container, and a weight of the pharmaceutical container.
  • the pharmaceutical master also includes information on an infusion container that contains an infusion such as physiological saline or glucose.
  • the information on the infusion container includes information such as an infusion identification information and a specific gravity of the infusion.
  • the pharmaceutical master may also include information for identifying drug combinations that are recommended to be administered early after mixing due to the possibility of compounding changes.
  • FIG. 5 is a perspective view showing an example of the configuration of the co-infusion unit 40.
  • Fig. 6 is a front view showing an example of the schematic configuration of the co-infusion unit 40, and is a diagram for explaining an example of the operation of the co-infusion unit 40.
  • Fig. 7 is a diagram for explaining adjustment of the needle tip position of the syringe 501.
  • the mixing unit 40 includes a syringe holder 41, a drug container holder 42, an infusion container holder 43, a stopper position detector 45, and a first detector 46.
  • the syringe holding unit 41 is a member that holds the syringe 501 (the syringe 501 transported by the first transport unit 110) for injecting a medicine into the infusion container 503.
  • the syringe 501 includes a syringe 5011, a needle 5014, and a plunger 5015.
  • the plunger 5015 is a pusher that moves in and out of the syringe 5011.
  • the plunger 5015 moves in and out of the syringe 5011 to draw medicine or the like into the syringe 5011 or to expel medicine or the like from the syringe 5011.
  • the infusion container 503 has a first surface SF1 and a second surface SF2.
  • the first surface SF1 and the second surface SF2 are opposite surfaces of the infusion container 503 and are the main surfaces of the infusion container 503.
  • the main surface of the infusion container 503 refers to the surface with the largest area among the multiple surfaces that make up the infusion container 503.
  • the infusion container 503 is stored so that the first surface SF1 and the second surface SF2 of the infusion container 503 face a predetermined direction.
  • the infusion container 503 is held on the rail section 36 of the infusion shelf 30 so that the first surface SF1 faces the back of the mixing device 1 and the second surface SF2 faces the front of the mixing device 1.
  • the second transport section 120 then sucks the first surface SF1 of the infusion shelf 30 to hold the infusion container 503, and transports and hands over the infusion container 503 to the infusion container holding section 43 without changing its orientation.
  • the mixing unit 40 rotates around the rotation axis Ax to extract the infusion from the infusion container 503.
  • the infusion container 503 is placed on the placement table 432 with the second surface SF2 abutting against the placement table 432.
  • the surface of the mounting base 432 is approximately parallel to the X-axis direction. Therefore, by rotating the mixing unit 40 around the rotation axis Ax and adjusting the rotational position of the mixing unit 40, the surface of the mounting base 432 can be oriented in a predetermined direction in which the first surface SF1 and the second surface SF2 of the infusion container 503 are oriented, without changing the orientation of the infusion container 503.
  • By orienting the surface of the mounting base 432 and the first surface SF1 and the second surface SF2 of the infusion container 503 in the same direction it is possible to prevent the shape of the infusion container 503 from being distorted when the infusion container 503 is brought into contact with the mounting base 432. It is also possible to prevent the position of the part of the infusion container 503 containing the liquid (e.g., the body of the infusion container 503) from moving when the infusion container 503 is brought into contact with the mounting base 432.
  • the first detection unit 46 detects the tip of the needle 5014 of the syringe 501 held by the syringe holding unit 41.
  • the syringe holding unit 41 moves downward when the needle 5014 is inserted into the drug container 502 held by the drug container holding unit 42 or the infusion container 503 held by the infusion container holding unit 43.
  • the first detection unit 46 detects the tip of the needle 5014 that moves with this downward movement.
  • the first detection unit 46 may be, for example, an optical sensor equipped with a light receiving unit that receives light reflected by the needle 5014.
  • the drug container holding unit 42 moves in a direction perpendicular to the needle 5014 ( ⁇ Y-axis direction). Therefore, the position of the drug container 502 in the up-down direction is approximately the same at the first puncture position indicated by reference number 1001 in FIG. 6 and the second puncture position indicated by reference number 1002 in FIG. 6. Therefore, the position of the rubber stopper 5021 detected by the stopper position detection unit 45 at the second puncture position can also be applied to the first puncture position. Therefore, the co-injection unit control unit 144 can puncture the rubber stopper 5021 with only the tip of the needle 5014 by moving the needle 5014 that has passed in front of the first detection unit 46 downward by the calculated distance.
  • the syringe holding part 41 is moved downward at a predetermined speed V.
  • the mixing unit control part 144 measures the second detection time T2 from when the second detection part 47 detects the syringe holding part 41 to when the first detection part 46 detects the needle 5014.
  • the mixing unit control part 144 can determine the tip position of the needle 5014 of the syringe 501 actually used in the mixing process when the second detection part 47 detects the syringe holding part 41 holding the syringe 501 actually used in the mixing process, from (second detection time T2-first detection time T1) x predetermined speed V and the tip position of the needle of the jig 601 stored in advance in the memory part 200.
  • [Specific configuration of the second conveying unit] 8 is a diagram showing an example of the configuration of the second transport unit 120.
  • the second transport unit 120 is a member that removes an infusion container 503 from the infusion shelf 30 in order to inject a medicine into the infusion container 503 indicated in the preparation data, for example.
  • the second transport unit 120 includes an adsorption unit 121 and a third reading unit 122 (reading unit).
  • the suction part 121 is a member that suctions the body part 5031 of the infusion container 503.
  • the suction part 121 is an example of a holding member that holds the infusion container 503, and as long as the second transport unit 120 can hold the infusion container 503, the holding member does not have to be the suction part 121.
  • the second transport control unit 145 detaches the infusion container 503 by controlling the air pressure in the suction part 121.
  • the main suction part 121A is always used to adsorb the infusion container 503 when the second transport part 120 holds the infusion container 503.
  • the main suction part 121A is provided in a position that allows it to face all of the infusion containers 503 of different sizes that can be stored in the co-infusion device 1.
  • the two sub-suction parts 121B adsorb the infusion container 503 together with the main suction part 121A depending on the vertical size of the infusion container 503. Therefore, at least one of the two sub-suction parts 121B may not adsorb the infusion container 503 depending on the size of the infusion container 503.
  • the positional relationship between the adsorption location of the infusion container 503 (e.g., the infusion shelf 30 and the mixing unit 40) and the second transport unit 120 is determined in advance so that the main adsorption unit 121A is always used.
  • the control unit 140 stores in a volatile memory the type of the infusion container 503 being transported by the second transport unit 120. Therefore, if the power supply of the co-infusion device 1 is turned off due to a power outage or the like while the second transport unit 120 is transporting the infusion container 503, the control unit 140 may not be able to manage the type of the infusion container 503 held by the second transport unit 120. In such a case, in the co-infusion device 1 after the power supply is turned on, the printing and inspection unit 50 affixes a label on which information indicating that the co-infusion process using the infusion container 503 may not have been performed correctly is printed to the infusion container 503 held by the second transport unit 120.
  • the information may be an example of second information different from the first information (described later).
  • the label is a label indicating the second information, and may be affixed in a position that does not overlap with the first label LA11 (see reference numeral 1061 in FIG. 20) like the second label LA12.
  • the label is affixed to area Ar11 on the second surface SF2, which faces the main suction portion 121A.
  • the positional relationship between the main suction portion 121A and the guide portion 56 (described later) of the printing and inspection unit 50 is determined in advance so that the label can be affixed to area Ar11.
  • the portion of the second surface SF2 opposite the portion that is suctioned by the suction portion 121 is less likely to move, allowing the label to be affixed more reliably.
  • Area Ar11 faces the portion that is suctioned on any infusion container 503. Therefore, by using area Ar11 as the label affixing position, the label can be affixed more reliably no matter what infusion container 503 is held by the second transport section 120.
  • the label may be attached by the user. At least a part of the label may be attached to the area Ar11.
  • the number of suction parts 121 is not limited to three, and may be one or a number other than three. When multiple suction parts 121 are provided, at least one of them should be the main suction part 121A.
  • the third reading unit 122 reads the first information contained in the first label LA11 (see reference numeral 1061 in FIG. 20) affixed to the body 5031 of the infusion container 503.
  • the first label LA11 is a label that is affixed in advance to the infusion container 503 by the pharmaceutical manufacturer that provides the infusion container 503, and is also referred to as an infusion label.
  • the first information read by the third reading unit 122 is, for example, infusion type information that indicates the type of infusion.
  • the third reading unit 122 includes a light receiving unit 1222 that receives light reflected on the surface of the infusion container 503.
  • the third reading unit 122 includes a light emitting unit 1221 that emits light toward the surface of the infusion container 503 stored in the infusion shelf 30, the light receiving unit 1222 may receive the light emitted by the light emitting unit 1221 that is reflected on the surface of the infusion container 503.
  • the third reading unit 122 reads the first information based on a change in the amount of light received by the light receiving unit 1222. If the first information is included in a barcode, the third reading unit 122 may be realized by a barcode reader.
  • the third reading unit 122 functions as a recognition unit that recognizes the orientation of the first surface SF1 of the infusion container 503. Specifically, the third reading unit 122 recognizes the orientation of the first surface SF1 based on a change in the amount of light received by the light receiving unit 1222. In this case, the third reading unit 122 can recognize the orientation of the first surface SF1 by functioning as an optical member. In this embodiment, when the third reading unit 122 can read the first information, the control unit 140 recognizes that the orientation of the first surface SF1 is a predetermined direction. In this embodiment, the predetermined direction is the rear direction of the co-infusion device 1 (the direction in which the third reading unit 122 is located when viewed from the infusion shelf 30).
  • the third reading unit 122 reads the first information contained in the first label LA11 from the infusion container 503 stored on the infusion shelf 30.
  • the first label LA11 is affixed to the first surface SF1. Therefore, when the second transport unit 120 removes the infusion container 503 from the infusion shelf 30, if the infusion container 503 is stored on the infusion shelf 30 such that the second transport unit 120 and the first label LA11 face each other, the third reading unit 122 can recognize that the orientation of the first surface SF1 is toward the back of the co-infusion device 1.
  • the control unit 140 determines whether the type of infusion indicated by the first information is the same as the type of infusion indicated in the preparation data, as a result of the third reading unit 122 reading the first information. If the control unit 140 determines that the two types are the same, it transports the infusion container 503 to the mixing unit 40 or the like, without reporting an error indicating that they are not the same. On the other hand, if the control unit 140 determines that the two types are not the same, it may report an error, or may place the infusion container 503 on the infusion receiving shelf 60 and remove another infusion container 503 from the infusion shelf 30.
  • Fig. 10 is a perspective view showing an example of the overall configuration of the syringe shelf 10 and the medicine container shelf 20.
  • Reference numeral 1025 in Fig. 11 is a diagram showing an example of the configuration of one syringe shelf 10 and one medicine container shelf 20 when viewed from the first transport unit 110 side.
  • Reference numeral 1026 in Fig. 11 is a diagram for explaining the medicine container shelf 20.
  • the syringe shelf 10 includes a plurality of equipment holding sections 11, an equipment transport section 12, an object detection section 13, and a syringe detection section 14. Note that an equipment holding section 11 is also attached to the attachment section 1211 of the equipment transport section 12 shown in FIG. 10, but is not shown in the figure.
  • the user Prior to the mixed injection process, the user loads the syringe 501 into the syringe shelf 10.
  • the syringe 501 is loaded into the syringe shelf 10 with the needle cap 5016 attached to the needle 5014.
  • a plurality of holes 172 are formed in the plate-like member 171 that defines each syringe shelf 10. This allows, for example, air purified by the air purification unit 130 (see FIG. 2) to flow efficiently from the top to the bottom of the co-infusion device 1.
  • the multiple equipment holding parts 11 are members capable of holding syringes 501.
  • one equipment holding part 11 holds one syringe 501, but one equipment holding part 11 may hold multiple syringes 501.
  • the equipment holding part 11 includes a free roller 1111 and an equipment clamping part 1112.
  • the equipment clamping portion 1112 clamps the syringe 501.
  • the equipment clamping portion 1112 clamps the flange 5013 of the syringe 501.
  • the equipment clamping portion 1112 is provided at a height such that the syringe 501 does not touch the plate-like member 171 when the syringe 501 is held by the equipment holding portion 11.
  • the pair of equipment clamping parts 1112 are biased in a direction approaching each other so that they can clamp the syringe 501.
  • the equipment clamping parts 1112 are spaced apart to a degree smaller than the width of the flange 5013 when they are not clamping the flange 5013.
  • the equipment clamping parts 1112 move in accordance with the shape of the flange 5013. This allows the equipment clamping parts 1112 to clamp the syringe 501.
  • a free roller 1111 that has a rotation axis extending in the vertical direction and can rotate on the XY plane is provided below the tip of the equipment clamping part 1112.
  • the free roller 1111 holds the vicinity of the flange 5013 of the syringe 5011 clamped by the equipment clamping part 1112.
  • the equipment transport unit 12 is a member that transports at least one of the multiple equipment holding units 11 to the working area Ar1.
  • the equipment transport unit 12 is an endless rotating member (rotating belt) to which the multiple equipment holding units 11 are connected. Therefore, in this embodiment, the equipment transport unit 12 transports the equipment holding units 11 one by one to the working area Ar1.
  • the equipment transport unit 12 may also be a transport unit that transports multiple equipment holding units 11 to the working area Ar1 at once.
  • the working area Ar1 is an area where the user causes at least one of the multiple equipment holding parts 11 to hold the syringe 501.
  • the working area Ar1 is also an area where the user removes the syringe 501 held by at least one of the multiple equipment holding parts 11.
  • the working area Ar1 is an area where the user causes one equipment holding part 11 to hold the syringe 501, and where the user removes the syringe 501 held by one equipment holding part 11.
  • the working area Ar1 may function only as an area where the user causes at least one of the multiple equipment holding parts 11 to hold the syringe 501. In this case, the area where the user removes the syringe 501 held in the equipment holding part 11 may be provided in a position separate from the working area Ar1.
  • the working area Ar1 may function only as an area where the user removes the syringe 501 held in the equipment holding part 11. In this case, the area where the user causes the syringe 501 to be held in the equipment holding part 11 may be provided in a position separate from the working area Ar1.
  • the equipment transport unit 12 transports another equipment holding unit 11 in place of the equipment holding unit 11 located in the working area Ar1 when the object detection unit 13 detects an object (e.g., the user's hand) and then stops detecting the object, triggering the transport unit 12 to transport another equipment holding unit 11 instead of the equipment holding unit 11 located in the working area Ar1.
  • the user's hand is inserted into the working area Ar1, the user causes the equipment holding unit 11 to hold the syringe 501, and then when the user's hand leaves the working area Ar1, the equipment transport unit 12 transports another equipment holding unit 11 to the working area Ar1.
  • the equipment transport unit 12 may transport another equipment holding unit 11 to the working area Ar1 when the syringe detection unit 14 detects the syringe 501 held by the equipment holding unit 11 or when the syringe detection unit 14 can no longer detect the syringe 501 held by the equipment holding unit 11.
  • the equipment transport unit 12 may transport another equipment holding unit 11 in place of the equipment holding unit 11 located in the working area Ar1 in response to a transport instruction from the user.
  • the syringe transport control unit 141 may receive the user's transport instruction via, for example, the touch panel 80.
  • the equipment transport unit 12 changes the equipment holding unit 11 located in the working area Ar1, for example by rotating counterclockwise. This transport operation makes it possible to transport to the working area Ar1 another equipment holding unit 11 not holding a syringe 501, in place of the equipment holding unit 11 holding the syringe 501 in the working area Ar1.
  • the object detection unit 13 is a member that detects an object inserted into the working area Ar1. In this embodiment, the object detection unit 13 detects the user's hand or arm inserted into the working area Ar1.
  • the syringe detection unit 14 is a member that detects the syringe 501 held in the equipment holding unit 11 located in the working area Ar1. In this embodiment, the syringe detection unit 14 detects the syringe 5011 when the syringe 501 is held in the equipment holding unit 11.
  • the storage unit 200 stores syringe inventory information indicating the type and number of syringes 501 stored in the syringe shelf 10.
  • the syringe inventory information stores information identifying each equipment holding unit 11, information indicating the type of syringe 501 held in each equipment holding unit 11, and information indicating the transport position of each equipment holding unit 11, in association with each other.
  • the control unit 140 then updates the syringe inventory information as appropriate in response to the loading of syringes 501 into the equipment holding units 11 of the syringe shelf 10 and the removal of syringes 501 from the equipment holding units 11.
  • the medicine container shelf 20 comprises a plurality of instrument holding sections 21, an instrument transport section 22, an object detection section 23, and a medicine container detection section 24. Also, as indicated by reference numeral 1025 in Figure 11, the medicine container shelf 20 comprises a first reading section 25 (reading section) and a roller driving section 26. Note that the instrument holding section 21 is also attached to the mounting section 221 of the instrument transport section 22 shown in Figure 10, but is not shown in the figure.
  • the drug container shelf 20 Prior to the co-injection process, the drug container shelf 20 is filled with drug containers 502 by the user.
  • the drug containers 502 are provided with rubber stoppers 5021 (see FIG. 5) that close the openings and lids that are placed on the rubber stoppers 5021.
  • the drug containers 502 are loaded into the drug container shelf 20 with the lids removed.
  • a plurality of holes 172 are formed in the plate-like member 171 that defines each drug container shelf 20.
  • the equipment transport unit 22 has the same function as the equipment transport unit 12. Specifically, the equipment transport unit 22 transports another equipment holding unit 21 in place of the equipment holding unit 21 located in the working area Ar2 when the object detection unit 23 detects an object (e.g., the user's hand) and then stops detecting the object, which is a trigger for the object transport unit 22. In addition to detecting the user's motion, the equipment transport unit 12 may transport another equipment holding unit 11 to the working area Ar2 when the drug container detection unit 24 detects the drug container 502 held by the equipment holding unit 21 or when the drug container detection unit 24 can no longer detect the drug container 502 held by the equipment holding unit 21. The equipment transport unit 12 changes the equipment holding unit 21 located in the working area Ar2 by, for example, rotating counterclockwise.
  • the drug container transport control unit 142 may transport another equipment holding unit 21 instead of the equipment holding unit 21 located in the working area Ar2, for example, in response to a transport instruction from the user.
  • the control unit 140 transports each of the drug containers 502 to the removal position PO11 at any timing, reads the type of drug contained in the drug container 502 from the barcode of the drug container 502 using the first reading unit 25, and stores the type of drug in the drug inventory information. This allows the control unit 140 to determine the position of the drug container 502 containing various drugs on the drug container shelf 20 based on the drug inventory information.
  • the drug container transport control unit 142 refers to the drug inventory information in the memory unit 200 to identify the drug container 502 to be removed that is required for the mixed injection process based on the preparation data, and controls the equipment transport unit 22 based on the transport position of the drug container 502 to transport the drug container 502 to the removal position PO11. For example, the drug container transport control unit 142 moves the equipment holding unit 21 corresponding to the drug container 502 to be removed to the removal position PO11, thereby transporting the drug container 502 to the removal position PO11.
  • the drug container transport control unit 142 when the drug container transport control unit 142 receives the issuance of preparation data after the first transport unit 110 removes the drug container 502 from the equipment holding unit 21, the drug container transport control unit 142 transports the equipment holding unit 21 holding the drug container 502 to be used in the next mixed injection process to the removal position PO11. However, even if the drug container transport control unit 142 does not receive the issuance of preparation data after the first transport unit 110 removes the drug container 502, the drug container transport control unit 142 may transport the equipment holding unit 21 holding the drug container 502 containing the same type of drug as the drug container 502 to the removal position PO11.
  • the drug container transport control unit 142 refers to the drug inventory information in the memory unit 200 to determine whether there is an equipment holding unit 21 that holds a drug container 502 that contains the same type of drug as the drug container 502 that the first transport unit 110 is trying to remove. If the drug container transport control unit 142 determines that there is an equipment holding unit 21 that holds the drug container 502, it transports the equipment holding unit 21 to the removal position PO11 regardless of whether or not the issuance of preparation data has been accepted.
  • the first transport control unit 143 when the first transport control unit 143 receives the issuance of preparation data, it can remove the drug container 502 from the removal position PO11 without waiting for the drug container 502 to be transported to the removal position PO11. Therefore, the control unit 140 can quickly start the mixing process based on the preparation data that will be sent to the mixing device 1 in the future, making it possible to shorten the overall time required for the mixing process.
  • the mixing device 1 may perform such processing when it allows consecutive mixing processes using the same type of drug by reusing the syringe 501 in order to conserve the number of syringes 501 used.
  • [Recovery of drug containers] 12 is a flowchart showing an example of the flow of processing by the control unit 140 when the control unit 140 receives an instruction to collect the medicine container 502. Note that the collection process described here may be executed to collect other equipment such as the syringe 501 or the infusion container 503.
  • the equipment transport unit 22 may transport the equipment holding unit 21, which holds the drug container 502 designated for collection, to the working area Ar2. This allows the user to easily collect the drug container 502 stored in the drug container shelf 20.
  • each of the multiple drug container shelves 20 enters the collection mode for collecting drug containers 502 held in the equipment holding section 21 is preset.
  • Information indicating the order is stored in the memory unit 200 in association with each drug container shelf 20.
  • Information regarding which drug containers 502 are designated as targets for collection is also stored in the memory unit 200.
  • the control unit 140 designates the drug container 502 as a target for collection.
  • the equipment transport unit 22 receives the collection instruction, it transports the equipment holding unit 21, which holds the drug container 502 whose drug identification information could not be read, to the working area Ar2.
  • the co-injection device 1 cannot use drugs contained in a drug container 502 whose drug identification information cannot be read, for co-injection processing. Therefore, by transporting the drug container 502 based on the above designation, the user can collect the drug container 502 that cannot be used in the co-injection processing.
  • the drug container transport control unit 142 determines that the above-mentioned collection instruction has been received (YES in S11), it refers to the memory unit 200 to select the drug container shelf 20 for which the smallest order in the above-mentioned collection mode has been set (S12). The drug container transport control unit 142 determines whether the status of the selected drug container shelf 20 indicates that the first transport unit 110 (removal unit) is removing the drug container 502 (drug container 502 being removed) (S13).
  • the above status is managed for each medicine container shelf 20 in the memory unit 200.
  • the control unit 140 sets the status of that medicine container shelf 20 to "medicine container 502 being removed.”
  • the control unit 140 determines that the first transport unit 110 has removed the medicine container 502 from the medicine container shelf 20, it sets the status of that medicine container shelf 20 to "medicine container 502 not being removed.”
  • the control unit 140 determines that the first transport unit 110 is holding the medicine container 502 and has moved a certain distance from the medicine container shelf 20, it sets the status of that medicine container shelf 20 to "medicine container 502 not being removed.”
  • the control unit 140 designates the number of drug containers 502 specified by the user as the drug containers 502 to be collected, giving priority to the drug containers 502 that are earliest in the storage order (earliest in the order of filling into the drug container shelf 20).
  • the drug container transport control unit 142 controls the instrument transport unit 22 to transport the above number of drug containers 502 to the working area Ar2. This allows the user to collect the desired number of drug containers 502, giving priority to the drug containers 502 that are earliest in the storage order.
  • the number of drug containers 502 specified by the user to be collected may be drug containers 502 containing the same type of drug. If there are no drug containers 502 that meet the above number on the selected drug container shelf 20, the drug container transport control unit 142 may take out the remaining drug containers 502 from other drug container shelves 20. If the above number is not specified, the drug container transport control unit 142 may transport all drug containers 502 to be collected to the work area Ar2 in any order regardless of the earlier in the holding order. Furthermore, as another embodiment, the drug container transport control unit 142 may be configured to transport the drug containers 502 with the later in the holding order to the work area Ar2 with priority, thereby being able to collect from the drug containers 502 with the later in the holding order.
  • the drug container transport control unit 142 may receive a selection operation via the touch panel 80 as to whether to collect from the drug container 502 with the later or earlier holding order, and may execute control to collect from the drug container 502 with the later or earlier holding order in accordance with the selection operation.
  • the drug container transport control unit 142 determines whether the equipment transport unit 22 has transported all of the drug containers 502 to be collected to the work area Ar2 in the selected drug container shelf 20 (S16). When the drug container transport control unit 142 determines that the transport of all of the drug containers 502 to be collected has not been completed (NO in S16), it executes the process of S15. Note that in steps S15 to S16, when the drug container 502 transported to the work area Ar2 cannot be detected by the drug container detection unit 24, the drug container transport control unit 142 determines that the collection of the drug container 502 has been completed, and repeats the process of transporting the next drug container 502 to be collected to the work area Ar2. This allows the user to collect all of the drug containers 502 to be collected.
  • the drug container transport control unit 142 determines whether there is another drug container shelf 20 that can be selected (S17). If the order of the collection mode set for the drug container shelf 20 selected in S12 is not the last order, the drug container transport control unit 142 determines that there is another drug container shelf 20 that can be selected.
  • the drug container transport control unit 142 determines that there are more drug container shelves 20 that can be selected (YES in S17), it selects the drug container shelf 20 that is set to the next drug container shelf 20 in the order set to the drug container shelf 20 selected in S12 (S18) and executes the process of S13. On the other hand, if the drug container transport control unit 142 determines that there are no more drug container shelves 20 that can be selected (NO in S17), it considers that the drug container 502 collection operation has been completed for all drug container shelves 20 and ends the process flow of FIG. 12.
  • the drug container transport control unit 142 transports the equipment holding unit 21 holding the drug container 502 designated as the collection target in the drug container shelf 20 whose order of going into collection mode has been set to an arbitrary order, to the work area Ar2.
  • the drug container transport control unit 142 After the drug container transport control unit 142 has completed transporting the equipment holding unit 21, it starts transporting the equipment holding unit 21 holding the drug container 502 designated as the collection target in the drug container shelf 20 whose order is set to the next of the arbitrary order, to the work area Ar2. This allows the drug container 502 collection operation to be performed for each drug container shelf 20, allowing the user to collect the drug containers 502 efficiently.
  • the drug container transport control unit 142 determines that the status of the selected drug container shelf 20 indicates that the drug container 502 is being removed (YES in S13), it executes the process of S17. Therefore, when it is the turn of the drug container shelf 20 from which the drug container 502 is being removed to be set to the collection mode, the drug container transport control unit 142 does not set the drug container shelf 20 in the collection mode, but sets the drug container shelf 20 set next in the order to the collection mode. Therefore, the user can collect the drug container 502 from the drug container shelf 20 set next in the order without waiting for the first transport unit 110 to remove the drug container 502. For the drug container shelf 20 that was not set to the collection mode, the drug container transport control unit 142 assigns the order of the collection mode to the next order of the drug container shelf 20 set in the collection mode, or to the last order.
  • the drug container transport control unit 142 also executes the process of S17 if it determines that the drug container 502 to be collected is not present on the selected drug container shelf 20 (NO in S14).
  • the drug container transport control unit 142 may also require a user operation when ending the collection mode before the collection operation is performed for all drug containers 502 designated as collection targets after changing the operation mode of the co-infusion device 1 to the collection mode based on a collection instruction from the user.
  • the drug container transport control unit 142 may end the collection mode when the drug container side door 27 of the drug container shelf 20 in which the drug container 502 to be collected is stored is opened and then closed after changing the operation mode of the co-infusion device 1 to the collection mode based on a collection instruction from the user. This can eliminate the need for an operation to end the collection mode.
  • the drug container transport control unit 142 may end the collection mode when the drug container side door 27 of the drug container shelf 20 in which the drug container 502 to be collected is stored is opened and then closed after changing the operation mode of the co-infusion device 1 to the collection mode based on a collection instruction from the user, and collection has been completed for all drug containers 502 designated as collection targets.
  • FIG. 13 is a perspective view showing an example of the configuration of the infusion shelf 30.
  • the infusion shelf 30 includes a pusher section 31, a pusher transport section 35, and a rail section 36 (hanging holder section).
  • the infusion shelf 30 includes a shutter 37.
  • the infusion shelf 30 Prior to the mixed injection process, the infusion shelf 30 is filled with infusion containers 503 by the user. As with the syringe shelf 10 and the drug container shelf 20, the plate-shaped member 301 defining each infusion shelf 30 has a plurality of holes 302 formed therein.
  • the rail section 36 is a member provided inside the infusion shelf 30 and extending from the infusion side door 34 (see FIG. 1) side toward the rear of the mixing device 1 (i.e., in the +Y-axis direction).
  • the end of the rail section 36 located on the infusion side door 34 side can be called the door side end 361, and the end located on the rear side of the mixing device 1 can be called the rear end 362.
  • the infusion container 503 is loaded into the rail section 36 from the door side end 361, and is removed from the rear end 362 by the second transport section 120. At least one infusion container 503 can be hung on the rail section 36.
  • the neck of the infusion container 503 can be hung between a pair of rail sections 36.
  • a flange 5034 which is a part of the neck 5033 of the infusion container 503, can be hung between a pair of rail sections 36.
  • each infusion shelf 30 is provided with three rail parts 36 corresponding to the three lanes.
  • the number of rail parts 36 provided on each infusion shelf 30 is not limited to three.
  • the upper infusion shelf 30 holds infusion containers 503 in an arrangement of five lanes in the left-right direction
  • the lower infusion shelf 30 holds infusion containers 503 in an arrangement of four lanes in the left-right direction
  • the upper infusion shelf 30 is provided with rail parts 36 corresponding to five lanes in the left-right direction
  • the lower infusion shelf 30 is provided with rail parts 36 corresponding to four lanes in the left-right direction.
  • each of the rail parts 36 is filled with the same type of infusion container 503 (infusion containers having the same type of infusion contained in the infusion container 503 and the same size of the infusion container 503).
  • the infusion containers 503 to be filled are determined for each infusion shelf 30. However, different types of infusion containers 503 may be loaded into each rail portion 36.
  • the pushing section 31 is a member that can move along the rail section 36 and pushes the infusion container 503 suspended from the rail section 36 from the door side end 361 to the rear end 362.
  • the pushing section 31 is connected to the pushing transport section 35.
  • the pushing transport section 35 is provided along the rail section 36.
  • the pushing transport section 35 operates under the control of the pushing control section 147, thereby being able to move the pushing section 31 along the rail section 36.
  • the pushing transport section 35 may be, for example, an endless rotating member.
  • the size of the pushing section 31 and the positional relationship between the rail section 36 and the pushing transport section 35 are specified so that the infusion container 503 suspended from the rail section 36 can be pushed in by the movement of the pushing section 31.
  • the pushing unit 31 When the infusion side door 34 is unlocked or open, the pushing unit 31 is located on the door side end 361 side and at a position PO31 where it does not interfere with the filling (hanging on the rail portion 36) of the infusion container 503. For example, when the operation unit corresponding to the upper infusion shelf 30 is pressed (when the infusion side door 34 is unlocked), the pushing control unit 147 may move the pushing unit 31 to position PO31 by controlling the pushing transport unit 35.
  • the pushing unit 31 pushes the infusion container 503 suspended from the rail portion 36 from the door side end 361 to the rear end 362.
  • the pushing control unit 147 controls the pushing transport unit 35 to move the pushing unit 31 from position PO31 to the rear end 362.
  • the rear end 362 of the wall that constitutes the infusion shelf 30 is provided with a detection unit (not shown) that detects the infusion container 503 present at the rear end 362.
  • the pushing control unit 147 moves the pushing unit 31 toward the rear end 362 until the detection unit detects the infusion container 503.
  • the printing and inspection unit control unit 148 determines whether the determined weight of the medicine mixture, 6.0 g, matches the difference between the second and third measurements. If the specific gravity of the infusion is 1.0, the printing and inspection unit control unit 148 determines that the weight of the drug mixture to be injected into the infusion container 503 is 5.5 g, calculated by adding up the weight of the infusion, 5.0, and the weight of the drug, 0.5, and determines whether the determined weight of 5.5 g matches the difference between the second and third weighings. In other words, the printing and inspection unit control unit 148 determines that the result of the second inspection process is appropriate if the difference between the second and third weighings matches the weight of the drug injected into the infusion container 503.
  • the control unit 140 may determine that the storage state of the infusion container 503 is not in a state in which the second label LA12 can be affixed. In this case, the touch panel control unit 149 may notify information indicating that the first information cannot be read from the infusion container 503, or information indicating the location where the infusion container 503 is stored. The third reading unit 122 may also continue operation of the co-infusion device 1 by reading the first information from an infusion container 503 stored in another location.
  • the third reading unit 122 recognizes whether the first surface SF1 faces a predetermined direction based on the result of reading the first information (the result of receiving light by the light receiving unit 1222).
  • a member different from the third reading unit 122 may be provided in the co-infusion device 1 as a recognition unit that recognizes whether the first surface SF1 faces a predetermined direction.
  • the recognition unit only needs to be able to recognize the orientation of the first surface SF1, and does not necessarily have to be realized by an optical member.
  • the application unit can apply the second information to the surface of the infusion container 503 so as not to overlap with the first information by attaching the second label LA12 to a surface of the infusion container 503 other than the first surface SF1 on which the first information is attached.
  • the application unit attaches the second label LA12 to the second surface SF2 opposite the first surface SF1, so that the second information can be applied to the surface of the infusion container 503 so as not to overlap with the first information.
  • the infusion receiving shelf 60 is provided with rails 62, so that the infusion containers 503 after drug injection can be suspended and held. Therefore, even infusion containers 503 that are difficult to stand on their own can be held in an aligned state.
  • the rails 62 can hold the infusion containers 503 in an aligned state, so that the user can easily remove them. Also, unlike the case where multiple infusion containers 503 after drug injection are placed on a tray (not shown), the rails 62 can hold the infusion containers 503 in an attractive manner and reduce the risk of damage to the infusion containers 503 due to collisions between the infusion containers 503.
  • the rail portion 62 extends in the front-rear direction ( ⁇ Y-axis direction) of the co-infusion device 1 and includes a first portion 621 to which the infusion container 503 is handed over by the second conveying portion 120, and a second portion 622 from which the infusion container 503 held by the rail portion 62 is removed.
  • the second transport unit 120 passes the infusion container 503 into which medication has been injected by the mixing unit 40 to the rail section 62 at the first portion 621. Specifically, the second transport unit 120 passes the infusion container 503 after medication injection, on whose second surface SF2 the second label LA12 has been affixed by the printing and inspection unit 50, to the rail section 62. The second transport unit 120 passes the infusion containers 503 after medication injection in sequence to the rail section 62, so that the rail section 62 holds the multiple infusion containers 503 in a row.
  • the second transport unit 120 transfers the infusion container 503 to the rail unit 62 with the second surface SF2 of the infusion container 503, to which the second label LA12 is affixed, facing in the direction seen from the first part 621 to the second part 622 (the -Y axis direction).
  • the second transport unit 120 adsorbs the first surface SF1 of the infusion container 503 to which the first label LA11 is affixed, and then affixes the second label LA12 to the second surface SF2 opposite the first surface SF1.
  • the second transport unit 120 moves the infusion container 503 to a position facing the infusion receiving shelf 60 while adsorbing the first surface SF1.
  • the second transport unit 120 moves to the infusion receiving shelf 60 side (the front direction of the co-infusion device 1; the -Y axis direction).
  • the second transport unit 120 transfers the infusion container 503 to the rail unit 62 so that the second surface SF2 to which the second label LA12 is affixed faces the front of the co-infusion device 1.
  • the infusion container 503 By transferring the infusion container 503 to the rail portion 62 in this manner, the infusion container 503 can be held on the infusion receiving shelf 60 with the second label LA12 facing forward, as shown in Figures 21 and 22. Then, when the user removes the infusion container 503 from the infusion receiving shelf 60, for example, the user can easily recognize the information indicated on the second label LA12 (information regarding the infusion container 503 after drug injection).
  • the rail portion 62 is provided on the infusion receiving shelf 60 at an incline such that the position of the second portion 622 is lower than the position of the first portion 621 when viewed from the left-right direction ( ⁇ X-axis direction) of the co-infusion device 1.
  • This allows the rail portion 62 to move the infusion container 503 held by the first portion 621 from the first portion 621 to the second portion 622 by the weight of the infusion container 503.
  • the rail portion 62 functions as a moving portion that moves the held infusion container 503 from the first portion 621 to the second portion 622.
  • the cross-sectional shape of the rail portion 62 perpendicular to the extension direction of the rail portion 62 satisfies the following two conditions: -
  • the support portions 626 of each of the pair of rail portions 62 are closer to each other than the dimensions of the neck portion 5033 of the infusion container 503. -
  • the pair of rail portions 62 slopes downward.
  • the cross-sectional shape of the pair of rail portions 62 is a shape that widens from the support portion 626 at the center.
  • the contact between the rail portion 62 and the neck portion 5033 is not surface contact, but point contact when the infusion container 503 is held as shown by reference numeral 1072 in FIG. 23. Also, when the infusion container 503 is held as shown by reference numeral 1073 in FIG. 23, the contact between the rail portion 62 and the neck portion 5033 is line contact. This improves the sliding of the infusion container 503 suspended from the rail portion 62.
  • the cross-sectional shape of the pair of rail portions 62 is not limited to the above-mentioned flared shape, and may be any shape that allows the pair of rail portions 62 to make point or line contact with the infusion container 503.
  • the infusion receiving shelf 60 may have a pair of rail portions 62A instead of the pair of rail portions 62.
  • the pair of rail portions 62A is held by a rail holding portion 69, similar to the pair of rail portions 62.
  • the pair of rail portions 62A is not a plate-shaped member like the pair of rail portions 62, but is a member having a support portion 626 that supports the infusion container 503 with a protruding shape.
  • the pair of rail portions do not have to be plate-shaped members or members having a protruding shape, and may be linear members that support the infusion container 503 by point contact or line contact.
  • the shape of the portion of the pair of rail portions that contacts the infusion container 503 when the infusion container 503 is hung on the pair of rail portions may be linear.
  • the second part 622 of the rail part 62 is provided with a shutter 63 (stopper) that prevents the movement of the infusion containers 503 held on the rail part 62.
  • the shutter 63 is biased in the closing direction of the shutter 63.
  • the shutter 63 is biased, for example, by a spring (not shown).
  • the shutter 63 is in a closed state under normal conditions, which reduces the possibility that the infusion containers 503 held on the rail part 62 will fall off the second part 622.
  • the user can open the shutter 63 according to the number of infusion containers 503 that he or she wishes to remove.
  • reference numeral 1081 shows the shutter 63 in a closed state
  • reference numeral 1082 shows the shutter 63 in an open state
  • the arrows pointing in the -Y-axis direction indicate the removal direction of the infusion container 503 held by the rail portion 62.
  • the shutter 63 is provided at one end of the pair of rail portions 62 so as to be rotatable around a rotation axis A63 whose axis is in the vertical direction.
  • the shutter 63 opens and closes the second portion 622 by rotating around the rotation axis A63.
  • a support portion 64 that supports the shutter 63 is connected to the rotation axis A63.
  • an abutment portion 65 against which the support portion 64 abuts extends from the end of the rail portion 62.
  • the support portion 64 rotates between the reference line L11 and the abutment portion 65.
  • the abutment portion 65 may be provided at a position where the infusion container 503 can be removed when the shutter 63 is at its widest opening.
  • the shutter 63 abuts against the infusion container 503 held by the rail portion 62, thereby preventing the infusion container 503 from moving in the removal direction.
  • the user grasps the leading infusion container 503 and pulls the infusion container 503 in the removal direction with a force equal to or greater than the biasing force of the spring (not shown).
  • This pulling causes the infusion container 503 to open while abutting against the shutter 63, allowing the user to remove the infusion container 503.
  • the shutter 63 is closed by the biasing force of the spring. This prevents the subsequent infusion containers 503 from moving in the removal direction. Therefore, the user can remove the leading infusion container 503 without performing any operation other than pulling the infusion container 503.
  • the user grasps the support portion 64 and rotates it toward the abutment portion 65 to maintain the shutter 63 in an open state.
  • the user releases the support portion 64, and the spring force causes the shutter 63 to close. Therefore, the user can remove the desired number of infusion containers 503 simply by operating the support portion 64. Note that the user may also operate the support portion 64 when removing a single infusion container 503.
  • the contact surface 631 of the shutter 63 with the infusion container 503 held on the rail portion 62 is inclined with respect to the removal direction (movement direction) of the infusion container 503 when the shutter 63 is in the closed state.
  • the contact surface 631 is inclined with respect to the removal direction when the shutter 63 is in the closed state so that the distance between the shutter 63 and the rail portion 62 on which the shutter 63 is not provided is shortened toward the removal direction.
  • the operating angle for opening the shutter 63 can be made smaller than when the abutment surface 631 is not inclined (when the abutment surface 631 is perpendicular to the extension direction of the rail portion 62 when the shutter 63 is closed). This improves the operability of opening and closing the shutter 63.
  • the shutter 63 can be closed immediately after the infusion container 503 is removed. This reduces the possibility that the infusion container 503 behind the removed infusion container 503 will be dispensed together with the removed infusion container 503.
  • Reference numeral 1083 in FIG. 24 shows an example of the vertical positional relationship between the rail portion 62 and the shutter 63
  • reference numeral 1084 shows an example of the positional relationship as a comparative example.
  • Reference numeral 1083 in FIG. 24 shows the shutter 63 in an open state.
  • the shutter 63 is located below a plane including the bottommost part of the rail portion 62. This means that the distance (height) H60 between this plane and the top surface of the shutter 63 is greater than 0. Therefore, as shown by reference numerals 1081 to 1083 in FIG. 24, the rail portion 62 and the shutter 63 can be overlapped so that they do not come into contact (interfere with each other).
  • the reference numeral OL of reference numerals 1081 to 1083 in FIG. 24 indicates the overlap position between the rail portion 62 and the shutter 63.
  • the printing/inspection unit 50 and the infusion receiving shelf 60 are positioned so that the second transport unit 120 can store the infusion container 503 to which the second label LA12 is affixed on the infusion receiving shelf 60 with the second surface SF2 facing the removal direction without changing the orientation of the infusion container 503.
  • the second transport unit 120 may change the orientation of the infusion container 503 that it is holding so that the infusion container 503 is stored on the infusion receiving shelf 60 with the second surface SF2 facing the removal direction.
  • the pair of rail portions 62 are fixed to the infusion receiving shelf 60, but may be detachable from the infusion receiving shelf 60.
  • the user can remove the pair of rail portions 62 from the infusion receiving shelf 60 while the infusion container 503 is being held therein, and take them outside the housing of the co-infusion device 1. Therefore, the infusion container 503 can be removed from the rail portions 62 outside the housing of the co-infusion device 1.
  • FIG. 25 is a block diagram showing an example of the overall configuration of the co-infusion system 100 according to an embodiment of the present invention.
  • the co-infusion system 100 includes a co-infusion device 1, a host system 2, a drug dispensing device 7, a co-infusion support device 8, and a collation terminal 9.
  • the host system 2 is connected to the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, and the collation terminal 9 wirelessly or by wire so as to be able to communicate with each other.
  • the co-infusion system 100 may be provided with one or more of the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, and the collation terminal 9.
  • the execution subject of various processes in the co-infusion system 100 described below is merely an example, and the execution subject of various processes in the co-infusion system 100 can be changed.
  • the upper system 2 is a computer including a control unit 201, a storage unit 202, an operation unit 203, a display unit 204, a printing unit 205, and a third recording unit 206.
  • the upper system 2 functions alone as an example of the co-infusion system according to the present invention.
  • the upper system 2 may cooperate with other devices such as the co-infusion device 1 and the co-infusion support device 8 to execute various processes.
  • a system including the upper system 2 and the other devices is an example of the co-infusion system according to the present invention.
  • the control unit 201 has a processor and memory that execute various programs.
  • the storage unit 202 is a storage means such as a hard disk that stores various programs for causing the control unit 201 to execute various processes.
  • the storage unit 202 also stores prescription data and preparation data.
  • the operation unit 203 is an operation means such as a keyboard, mouse, and touch panel that allows the control unit 201 to accept user operations.
  • the display unit 204 is an output means such as a liquid crystal display or an organic EL display that presents information to the user.
  • various operations by the user in the upper system 2 are performed on the operation unit 203, and the display of various information in the upper system 2 is performed by the display unit 204.
  • the printing unit 205 is a printer that prints various information on a sheet based on the preparation data, and is connected to the upper system 2 for use.
  • the third recording unit 206 is a label printer that prints various information on a recording medium such as a label, and is connected to the upper system 2 for use.
  • the third recording unit 206 may also record various information on other types of recording media such as IC tags, not limited to recording media such as labels.
  • the control unit 201 also manages a system clock that keeps track of the time used in various processes in the higher-level system 2, and is able to obtain the time on that system clock as the current time.
  • the control unit 201 controls the system clock using a hardware clock such as a real-time clock.
  • the time kept by the system clock may include the date.
  • the time indicated by the system clock managed by the control unit 201 may be referred to as the system time.
  • control unit 201 transmits to the mixing device 1 an instruction to execute the mixing process and an instruction to execute a recording process to record the second information on the second label LA12 for the preparation data assigned to the mixing device 1.
  • control unit 201 does not cause the second information to be recorded on the second label LA12 by the second recording unit 704 and the second recording unit 804, etc., which are provided separately from the mixing device 1, for the preparation data assigned to the mixing device 1.
  • the control unit 201 transmits an instruction to execute the mixing process to the mixing device 1, it does not transmit an instruction to execute the recording process for the preparation data corresponding to the mixing process to the other drug dispensing device 7 or the mixing support device 8.
  • the control unit 201 causes the second recording unit 704 or the second recording unit 705 to record the second information on the second label LA12.
  • the control unit 201 transmits an instruction to execute the recording process to the drug dispensing device 7 or the co-infusion support device 8, and the recording process is executed by the second recording unit 704 or the second recording unit 705.
  • control unit 201 may automatically execute a process to change the execution subject of the recording process of the second label LA12 from the printing/inspection unit 50 of the co-infusion device 1 to another recording unit such as the second recording unit 704 or the second recording unit 705, or may execute the process when a confirmation operation is performed by the user.
  • control unit 201 may cause the third recording unit 206 to print the second information on the second label LA12 only for preparation data for which the co-infusion process in the co-infusion device 1 has been canceled.
  • the third recording unit 206 may be used only when printing the second label LA12 corresponding to preparation data for which the co-infusion process in the co-infusion device 1 has been canceled. This allows the user to easily understand that the co-infusion process based on the preparation data in the co-infusion device 1 has been canceled by the printing of the second label LA12 from the third recording unit 206.
  • the drug dispensing device 7 has a plurality of storage units corresponding to a plurality of types of drugs used as injection drugs, and can dispense a drug container from the storage unit while it is placed on a transport tray TR based on preparation data that is the target of the mixed injection process.
  • the drug container is an ampoule, a vial, an injection kit, a PTP sheet, or the like containing a drug.
  • the transport tray TR is also used to place an infusion container after the drug is mixed by a mixed injection process based on the preparation data and transport it to a hospital ward or a drug administration site.
  • An example of the drug dispensing device 7 is disclosed in, for example, JP 2015-013177 A or WO 2019/093413 A, so a detailed description of the drug dispensing device 7 will be omitted here and only an outline will be described.
  • the drug dispensing device 7 includes a control unit 701, a memory unit 702, a printing unit 703, a second recording unit 704, and the like.
  • the control unit 701 has a processor and memory that execute various programs.
  • the memory unit 702 is a storage means such as a hard disk that stores various programs for causing the control unit 701 to execute various processes, and also stores corresponding information, which will be described later.
  • the printing unit 703 is a printer that prints various information such as the type and number of drugs and infusions indicated in the preparation data on a sheet and outputs it as an injection prescription (an example of a printed sheet).
  • the second recording unit 704 is a label printer that prints various information on a second label LA12 that is affixed to the infusion container.
  • the second recording unit 704 is not limited to a recording medium such as a label, and when another type of recording medium such as an IC tag is attached to the infusion container, various information may be recorded on the recording medium.
  • the injection prescription printed by the printing unit 703 and the second label LA12 printed by the second recording unit 704 are dispensed in a state in which they are placed on the transport tray TR1 together with the drug container.
  • the transport tray TR1 is transported by a transport means such as a belt conveyor to the outlet for the second label LA12 printed by the second recording unit 704, the outlet for the injection prescription printed by the printing unit 703, and the outlet for the drug container dispensed from the drug dispensing device 7, in that order, so that the second label LA12, the injection prescription, and the drug container are placed on the transport tray TR1 in that order.
  • the drug dispensing device 7 may be configured to be able to dispense an infusion container containing an infusion, and the infusion container is placed on the transport tray TR1 in the same manner as the drug container.
  • a plurality of divided regions TR11 may be provided on the transport tray TR1, and a drug container, a second label LA12, and an injection prescription corresponding to one preparation data may be placed in one divided region TR11 (see, for example, JP 2015-013177 A).
  • drug containers, second labels LA12, and injection prescriptions corresponding to multiple preparation data are placed in the divided regions TR11 corresponding to each preparation data. Therefore, for example, drug containers, second labels LA12, and injection prescriptions corresponding to multiple preparation data corresponding to multiple patients may be placed in one transport tray TR1.
  • the multiple preparation data assigned to one transport tray TR1 are preset by the upper system 2.
  • multiple preparation data that are the same group, such as the same hospital room or ward, that are preset, are assigned to the divided regions TR11 of one transport tray TR1. This allows the user to transport transport trays TR1 carrying medication containers, etc., for patients in the same group to a room or ward, etc., all at once.
  • the user will have to manually prepare the infusion containers. Also, for types of drugs that are not loaded onto the drug dispensing device 7, the user will have to manually prepare the drug containers. Furthermore, the user may manually perform a mixing process in which drugs contained in drug containers held in the transport tray TR1 are mixed into an infusion container.
  • the mixed injection support device 8 executes various processes to support the mixed injection process performed manually by a user such as a pharmacist.
  • the preparation support device 8 is a personal computer or the like equipped with a control unit 801, a storage unit 802, a display unit 803, a second recording unit 804, and the like.
  • the control unit 801 has a processor and a memory that execute various programs.
  • the storage unit 802 is a storage means such as a hard disk that stores various programs for causing the control unit 801 to execute various processes.
  • the display unit 803 is an output means such as a liquid crystal display or an organic EL display for presenting information to a user.
  • the second recording unit 804 is a label printer or the like that prints various information on the second label LA12 that is affixed to the drug container, and is used by being connected to the mixed injection support device 8.
  • the second recording unit 804 may be a unit that records various information on other types of recording media such as IC tags, not limited to recording media such as labels.
  • the control unit 801 then sequentially displays on the display unit 803 information to assist a user who manually performs the mixing process based on the preparation data input from the higher-level system 2 as the target for the mixing process.
  • the control unit 801 executes a mixing support process that displays the types of drug containers, infusion containers, and syringes used in the mixing process based on the preparation data, and sequentially displays one or more work steps for injecting the drug contained in the drug container into the infusion container with the syringe.
  • the control unit 801 also causes the second recording unit 804 to print on the second label LA12 various types of information based on the preparation data that is the target for the mixing process in the mixing support device 8.
  • the collation terminal 9 is an information terminal including a control unit 901, a memory unit 902, a code reading unit 903, a display unit 904, and the like.
  • the collation terminal 9 is a portable terminal that can be carried by a user, such as a smartphone or a PDA.
  • the control unit 901 has a processor and a memory that execute various programs.
  • the memory unit 902 is a storage means such as a hard disk that stores various programs for causing the control unit 901 to execute various processes, and also stores corresponding information, which will be described later.
  • the code reading unit 903 is a barcode reader that reads information from codes such as one-dimensional codes and two-dimensional codes.
  • the display unit 904 is an output means such as a liquid crystal display or an organic EL display that presents information to a user.
  • a barcode reader such as the code reading unit 903 may be connected to the upper system 2, and the upper system 2 may have the function of the collation terminal 9.
  • the control unit 201 of the upper system 2 selects the preparation data to be subjected to the co-infusion process by outputting it to the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, etc., and executes a data output process (see FIG. 26) for allocating the preparation data to the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, etc. Then, the co-infusion device 1, the drug dispensing device 7, and the co-infusion support device 8 execute various processes with the preparation data allocated to the device itself as the execution target of the co-infusion process in a predetermined order.
  • the control unit 201 when executing the data output process is an example of a data output processing unit according to the present invention.
  • the allocation of the preparation data is performed by outputting the preparation data, but is not limited to this.
  • the control unit 201 may allocate each of the preparation data to the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, etc., store the allocation result in the storage unit 202, and notify the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, etc.
  • the mixed injection device 1, the drug dispensing device 7, the mixed injection support device 8, etc. acquire the preparation data assigned to themselves by reading the preparation data from the memory unit 202 of the higher-level system 2 as necessary.
  • step S1 the control unit 201 judges whether or not to execute the temporary fastening process including steps S2 to S3 described below. For example, the control unit 201 judges to execute the temporary fastening process when a temporary fastening operation for executing the temporary fastening process is performed on the operation unit 203. The control unit 201 may also judge to automatically execute the temporary fastening process when a specific timing such as a preset time arrives. Then, when it is judged that the temporary fastening process is to be executed (S1: Yes), the process proceeds to step S2, and when it is judged that the temporary fastening process is not to be executed (S1: No), the process proceeds to step S4.
  • step S2 the control unit 201 executes a process for generating provisional tightening data to be transmitted to the co-infusion device 1. Specifically, the control unit 201 extracts provisional target prescription data to be provisionally tightened from among a plurality of prescription data stored in the storage unit 202 based on a preset extraction condition, and generates provisional tightening data based on each of the provisional target prescription data. The control unit 201 may also display a list of a plurality of prescription data stored in the storage unit 202 on the display unit 204, and select provisional target prescription data to be provisionally tightened from among the plurality of prescription data in response to a user operation of the operation unit 203.
  • the provisional tightening data includes information on the type and number of equipment such as syringes, drug containers, and infusion containers required to perform the co-infusion process in the co-infusion device 1 based on at least a plurality of provisional target prescription data.
  • the provisional tightening data also includes an order number, administration time, and patient identification information corresponding to each of the prescription data.
  • step S3 the control unit 201 executes a provisional fastening data output process for outputting the provisional fastening data generated in step S2. Specifically, the control unit 201 stores the provisional fastening data in the storage unit 202 and transmits the provisional fastening data to the co-infusion device 1.
  • the steps S1 to S3 are processes executed to specify the type and number of equipment required for the co-infusion process executed by the co-infusion device 1 before the preparation data is transmitted from the upper system 2 to the co-infusion device 1, but in other embodiments, the steps S1 to S3 may be omitted.
  • Step S4 the control unit 201 determines whether or not to execute the closing process. For example, the control unit 201 determines to execute the closing process when a closing operation for executing the closing process is performed on the operation unit 203.
  • the closing process is an example of a specific process according to the present invention.
  • the control unit 201 may automatically determine to execute the closing process when a specific timing such as a preset time arrives. If it is determined that the closing process is to be executed (S4: Yes), the process proceeds to step S5, and if it is determined that the closing process is not to be executed (S4: No), the process proceeds to step S1.
  • the provisional closing process and the closing process may each be executed only once a day, or may be executed at multiple times.
  • the number of prescriptions displayed in area A1 is the number of preparation data generated based on prescription data in Rp units. Therefore, the number of prescriptions displayed in area A1 may not match the number of prescription data input to the higher-level system 2.
  • the prescription data input to the higher-level system 2 has only one Rp data
  • the prescription data does not need to be broken down into Rp units, and the number of prescriptions displayed in area A1 matches the number of prescription data input to the higher-level system 2.
  • the closing time condition is "00:00 to 07:49” and the implementation time condition is set to "0".
  • the implementation time condition "0" is a value for setting the restriction of use of the support device regardless of the administration time. Therefore, when the closing system time belongs to the group of the closing time condition "00:00 to 07:49", the control unit 201 restricts the use of the support device for the mixed injection process based on the preparation data regardless of the administration time corresponding to the preparation data.
  • the control unit 201 may restrict a user operation for setting the time between the end time of the tightening time condition and the start time of the implementation time condition to be shorter than a preset shortest time (e.g., 2 hours). This makes it possible to ensure at least the shortest time as the time between the end time of the tightening time condition and the start time of the implementation time condition. For example, after either the end time of the tightening time condition or the start time of the implementation time condition is input, the control unit 201 may prohibit the input of the other if the time between the end time of the tightening time condition and the start time of the implementation time condition is shorter than the shortest time.
  • a preset shortest time e.g. 2 hours
  • the preparation method selection process is a process executed for each of the preparation data identified as the target for executing the mixed injection process.
  • the control unit 201 when executing the preparation method selection process is an example of a selection processing unit.
  • step S701 the control unit 201 judges whether to restrict the use of the support device for the mixed injection processing based on the preparation data to be executed based on the closing management information.
  • the process proceeds to step S711, and if it is judged that the use of the support device is not to be restricted (S701: No), the process proceeds to step S702.
  • the process from step S702 onwards is a step in which the use of a support device such as the mixed injection device 1 or the mixed injection support device 8 may be selected
  • the process from step S711 onwards is a step in which the use of a support device such as the mixed injection device 1 or the mixed injection support device 8 is not selected. That is, the control unit 201 can restrict the use of the support device for the mixed injection processing based on the preparation data by shifting the process to step S711 in the preparation method selection process executed for the preparation data to be executed.
  • control unit 201 determines to restrict the use of the assistance device for the co-injection process based on the preparation data to be executed, it is also possible to suspend the closing process until the user performs a confirmation operation.
  • step S701 the control unit 201 determines whether the preparation data satisfies the restriction condition for restricting the use of the support device based on the closing system time and the administration time corresponding to the preparation data to be executed, and the closing management information. More specifically, the control unit 201 refers to the record corresponding to the group of the closing time condition to which the closing system time belongs in the closing management information, and if the administration time corresponding to the preparation data is outside the range of the execution time condition, determines to restrict the use of the support device for the mixed injection process based on the preparation data.
  • control unit 201 selects an assisted preparation method such as the fourth preparation method or the fifth preparation method described below that does not use the support device as a preparation method for the mixed injection process based on the preparation data based on the closing system time and the administration time.
  • control unit 201 determines to restrict the use of the support device for the mixed injection process based on the preparation data regardless of the administration time even when the execution time condition is "0".
  • the restriction condition includes that the administration time of the drug corresponding to the preparation data to be executed is outside the range of the execution time condition corresponding to each closing system time.
  • control unit 201 refers to the record in the closing management information that corresponds to the group of the closing time conditions to which the closing system time belongs, and if the administration time corresponding to the preparation data is within the range of the implementation time conditions, it determines that the use of the support device will not be restricted for the mixed injection process based on the preparation data.
  • the user can arbitrarily set the closing time condition and the implementation time condition in advance, thereby enabling operation to switch whether or not to use the assistance device depending on the closing system time and the administration time, thereby realizing a highly convenient co-infusion assistance system 100.
  • the user can set the closing time condition and the implementation time condition so that the use of the assistance device is restricted when the remaining time from the closing system time to the administration time becomes short.
  • the closing time condition and the implementation time condition are set in correspondence with each other in the closing management information.
  • the implementation time condition may be set based on the closing system time.
  • the control unit 201 may be configured to restrict the use of the support device for mixed injection processing based on preparation data whose administration time arrives before a preset threshold time has elapsed from the closing system time. In this case, the control unit 201 sets the threshold time in place of the implementation time condition in correspondence with each closing time condition in response to a user operation.
  • the control unit 201 refers to a record in the closing management information corresponding to the group of the closing time condition to which the closing system time belongs, and when the difference between the closing system time and the administration time is equal to or less than the threshold time set in the record, it determines that the use of the support device is restricted for mixed injection processing based on the preparation data. That is, in other embodiments, the restriction condition may include that the difference between the specific time and the implementation time corresponding to the preparation data is equal to or less than a preset threshold time. On the other hand, when the difference between the closing system time and the administration time exceeds the threshold time, the control unit 201 determines that the use of the support device for the mixed injection process based on the preparation data is not restricted. Also, the threshold time may be set commonly to all the closing system times, rather than being set for each group of the closing time conditions.
  • the implementation time condition or the threshold time is set for each closing time condition, but in other embodiments, the implementation time condition or the threshold time may be set for any one or more combinations of the closing time condition, the second group (such as the name of the hospital ward), and the prescription category.
  • the control unit 201 determines whether or not to restrict the use of the assistance device for the mixed injection process based on the preparation data based on the preparation data, based on the closing system time, the administration time corresponding to the preparation data, the second group to which the preparation data belongs, and the prescription category to which the preparation data belongs.
  • control unit 201 may notify that effect to a ward terminal provided in a ward or the like, or a pre-set terminal such as a portable terminal of a pharmacist in charge of ward duties.
  • a notification to the effect that the use of the support device is to be restricted may be sent from the higher-level system 2 to the other system such as the electronic medical record, and then sent from the other system to a terminal such as a ward terminal or the portable terminal.
  • some or all of the processing executed by the control unit 201 of the higher-level system 2 may be executed by a control unit of the other system such as an electronic medical record.
  • step S702 if the co-infusion method selected in step S6 is "mechanical co-infusion" (S702: Yes), the control unit 201 transitions the processing to step S721, and if the co-infusion method is not "mechanical co-infusion” (S702: No), the control unit 201 transitions the processing to step S702.
  • step S721 if the control unit 201 determines that the co-infusion process cannot be executed in the co-infusion device 1 for the preparation data to be executed (S721: Yes), it transitions the processing to step S703, and if the control unit 201 determines that the co-infusion process can be executed in the co-infusion device 1 (S721: No), it transitions the processing to step S722.
  • Step S722 the control unit 201 selects the first preparation method as the preparation method of the preparation data to be executed.
  • the first preparation method is an example of an assisted preparation method in which the co-infusion device 1 is used.
  • the first preparation method is a method in which the co-infusion device 1 executes the co-infusion process based on the preparation data, and the drug dispensing device 7 prints an injection prescription and places it on the transport tray TR1 without dispensing the drug container and printing the second label LA12.
  • the second label LA12 is printed by the co-infusion device 1 rather than the drug dispensing device 7 and affixed to the infusion container. That is, when the preparation method is the first preparation method, the control unit 201 assigns the preparation data as the co-infusion process to be executed by the co-infusion device 1 and the drug dispensing process to be executed by the drug dispensing device 7.
  • step S703 if the payout method selected in step S6 is "machine payout" (S703: Yes), the control unit 201 transitions the processing to step S704, and if the payout method is not "machine payout” (S703: No), the control unit 201 transitions the processing to step S731.
  • step S703 the control unit 201 branches the process according to the dispensing method selected in step S6.
  • step S721 for the second group to which the preparation data determined in step S721 that the mixing process in the mixing device 1 belongs, "mechanical dispensing" or “manual dispensing” may not be selected as the dispensing method in step S6.
  • the control unit 201 may branch the process depending on whether the drug container used in the mixing process based on the preparation data to be executed can be dispensed from the drug dispensing device 7.
  • control unit 201 shifts the process to step S704, and if the drug container used in the mixing process based on the preparation data to be executed cannot be dispensed from the drug dispensing device 7, the control unit 201 shifts the process to step S731.
  • the dispensing method may be "manual dispensing" regardless of the setting content in step S6, and the process may proceed to step S703. Also, for preparation data for which it is determined in step S721 that the mixing process in the mixing device 1 cannot be executed, the dispensing method may be "mechanical dispensing" regardless of the setting content in step S6, and the process may proceed to step S731.
  • step S704 if the control unit 201 determines that the mixed injection process is to be assisted by the mixed injection support device 8 (S704: Yes), the control unit 201 shifts the process to step S705, and if the control unit 201 determines that the mixed injection process is not to be assisted by the mixed injection support device 8 (S704: No), the control unit 201 shifts the process to step S741. Specifically, in the upper system 2, whether or not the user executes the mixed injection process without the assistance of the mixed injection support device 8 is set in advance for each of the second groups (wards). Then, the control unit 201 determines whether or not the preparation data is preparation data for which the user receives assistance from the mixed injection support device 8 according to the second group to which the preparation data belongs.
  • the co-infusion method is "manual co-infusion" and the co-infusion process is performed manually by a user in a hospital ward or the like, the user may perform the co-infusion process without assistance from the co-infusion support device 8. In this case, the second label LA12 will not be printed by the co-infusion support device 8.
  • step S705 the control unit 201 selects the second preparation method as the preparation method of the preparation data to be executed.
  • the second preparation method is an example of an assisted preparation method in which the mixed injection support device 8 is used.
  • the second preparation method is a method in which the drug dispensing device 7 executes dispensing of a drug container and printing of an injection prescription, places the drug container and the injection prescription on the transport tray TR1 and dispenses them, and the user manually executes the mixed injection process with the support of the mixed injection support device 8.
  • the second label LA12 is printed by the mixed injection support device 8 rather than the mixed injection device 1 and the drug dispensing device 7, and is affixed to the infusion container by the user.
  • the control unit 201 assigns the preparation data as the drug dispensing process to be executed by the drug dispensing device 7, and assigns the mixed injection support process including the printing process of the second label LA12 to be executed by the mixed injection support device 8.
  • step S741 the control unit 201 selects the fourth preparation method as the preparation method of the preparation data to be executed.
  • the fourth preparation method is an assisted preparation method in which an assisting device such as the co-infusion device 1 and the co-infusion assisting device 8 is not used.
  • the fourth preparation method is a method in which the drug dispensing device 7 executes dispensing of the drug container, printing of the second label LA12, and printing of the injection prescription, places the drug container, the second label LA12, and the injection prescription on the transport tray TR1 and dispenses them, and the user manually executes the co-infusion process without assistance from the co-infusion assisting device 8.
  • the second label LA12 is printed by the drug dispensing device 7 and is affixed to the infusion container by the user. That is, when the preparation method is the fourth preparation method, the control unit 201 assigns the preparation data as the drug dispensing process and the printing process of the second label LA12 to be executed by the drug dispensing device 7.
  • step S731 the control unit 201, like step S704, judges whether or not to receive assistance from the mixed injection support device 8 in the mixed injection process and branches the process. Specifically, when the control unit 201 judges that assistance from the mixed injection support device 8 is to be received in the mixed injection process (S731: Yes), the control unit 201 shifts the process to step S732, and when the control unit 201 judges that assistance from the mixed injection support device 8 is not to be received in the mixed injection process (S731: No), the control unit 201 shifts the process to step S733.
  • step S732 the control unit 201 selects the third preparation method as the preparation method of the preparation data to be executed.
  • the third preparation method is an example of an assisted preparation method in which the mixed injection support device 8 is used.
  • the third preparation method is a method in which the drug dispensing device 7 prints an injection prescription and places it on the transport tray TR1 without dispensing the drug container and printing the second label LA12, and the user manually arranges the drug containers and manually executes the mixed injection process with the support of the mixed injection support device 8.
  • the second label LA12 is printed by the mixed injection support device 8 rather than the mixed injection device 1 and the drug dispensing device 7, and is attached to the infusion container by the user. That is, when the preparation method is the third preparation method, the control unit 201 assigns the preparation data to be used to execute the mixed injection support process including the printing process of the second label LA12 by the mixed injection support device 8.
  • the control unit 201 selects the fifth preparation method as the preparation method of the preparation data to be executed.
  • the fifth preparation method is an assisted preparation method in which an assisting device such as the co-infusion device 1 and the co-infusion assisting device 8 is not used.
  • the fifth preparation method is a method in which the drug dispensing device 7 prints the second label LA12 and the injection prescription, places the second label LA12 and the injection prescription on the transport tray TR1 and dispenses them, and the user manually arranges the drug containers and manually executes the co-infusion process without assistance from the co-infusion assisting device 8.
  • the second label LA12 is printed by the drug dispensing device 7 and is attached to the infusion container by the user.
  • the control unit 201 does not assign the preparation data to be used for the drug dispensing process by the drug dispensing device 7, but assigns the preparation data to be used for the printing process of the second label LA12 by the drug dispensing device 7.
  • Step S711 As described above, when it is determined in step S701 that the use of the support device is to be restricted for the mixed injection process based on the preparation data to be executed, the process proceeds to step S711. Then, in step S711, when the dispensing method selected in step S6 is "machine dispensing" (S711: Yes), the control unit 201 transfers the process to step S741, and when it is not "machine dispensing" (S711: No), the control unit 201 transfers the process to step S733.
  • control unit 201 when the control unit 201 restricts the use of the support device for the mixed injection process based on the preparation data to be executed, and when the dispensing method is "machine dispensing", the control unit 201 selects the fourth preparation method as the preparation method of the preparation data to be executed. On the other hand, when the control unit 201 restricts the use of the support device for the mixed injection process based on the preparation data to be executed, and when the dispensing method is not "machine dispensing", the control unit 201 selects the fifth preparation method as the preparation method of the preparation data to be executed.
  • the preparation method candidates selected by the control unit 201 do not need to be all of the first preparation method to the fifth preparation method, but may be selected from the first preparation method and at least one of the second preparation method to the fifth preparation method.
  • control unit 201 executes, as an example of a method of restricting the use of the support device, not using either the mixing device 1 or the mixing support device 8 for the mixing process based on the preparation data.
  • the method of restricting the use of the support device may include a situation in which the mixing device 1 is not used and the mixing support device 8 is used. That is, when it is determined in step S701 that the use of the support device is restricted, the process may proceed to step S703, so that the second preparation method or the third preparation method may be selected, not limited to the fourth preparation method and the fifth preparation method.
  • the method of restricting the use of the support device may include a situation in which the mixing device 1 is used and the mixing support device 8 is not used.
  • the support device may include various devices that support part or the whole of the mixing process executed based on the preparation data, not limited to the mixing device 1 that supports the entire mixing process by executing the mixing process and the mixing support device 8 that supports part of the mixing process by displaying the contents of the work performed by the user in the mixing process.
  • the administration time is used as an example of the implementation time in the present invention.
  • the preparation data or the like contains information on the execution time of the mixing process based on the preparation data
  • the execution time of the mixing process may be used as the implementation time.
  • the control unit 201 may be able to set the range of the execution time of the mixing process instead of the administration time in the closing management information, or may be able to select either the administration time or the execution time of the mixing process and set the time range.
  • the host system 2 determines whether or not to restrict the use of the support device, but in other embodiments, the co-injection device 1 or the co-injection support device 8 may determine whether or not to restrict the use of the co-injection device 1 or the co-injection support device 8.
  • the control unit 140 may acquire the closing management information from the host system 2, and determine whether or not to restrict the use of the co-injection device 1 for the co-injection process based on the preparation data to be executed based on the closing management information.
  • the co-injection device 1 determines that the use of the co-injection device 1 should be restricted for the co-injection process based on the preparation data to be executed, it is considered that the same process as when the co-injection process based on the preparation data is canceled is executed.
  • control unit 201 selects the preparation method based on other conditions such as whether or not machine co-infusion is selected (S702) and whether or not machine dispensing is selected (S704) in addition to the closing system time and the administration time (see FIG. 40).
  • control unit 201 may be configured to select either an assisted preparation method using the assistance device or a preparation method not using the assistance device based on the closing system time and the administration time.
  • the co-injection system 100 may be provided with either one of the co-injection device 1 or the co-injection support device 8. For example, if the co-injection device 1 is provided and the drug dispensing device 7 and the co-injection support device 8 are not provided, the fifth preparation method is selected when it is determined in step S701 that the use of the co-injection device 1 is to be restricted (S701: Yes), and the first preparation method is selected when it is determined that the use of the co-injection device 1 is not to be restricted (S701: No).
  • step S8 the control unit 201 executes an allocation process for allocating the preparation data to be executed to the transport tray TR1.
  • the transport tray TR1 is provided with a code BC1 including tray identification information that can identify the transport tray TR1
  • each divided region TR11 is provided with a code BC21 including area identification information that can identify the divided region TR11.
  • the control unit 201 allocates the preparation data in the same second group to the divided regions TR11 of the transport tray TR1 in order of four preparation data in the same second group for the preparation data to be executed. That is, the preparation data allocated to the same transport tray TR1 belong to the same second group. In this case, for example, preparation data of not only one patient but also multiple patients may be assigned to multiple divided regions TR11 in the transport tray TR1.
  • step S9 the control unit 201 assigns the preparation data belonging to each of the second groups being executed to the co-infusion device 1, the drug dispensing device 7, or the co-infusion support device 8 using an output method in accordance with the preparation method selected in step S7, and executes a process of outputting the preparation data to the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, etc.
  • the control unit 201 outputs the preparation data to the mixing device 1, and outputs the preparation data and a first dispensing instruction indicating that drug dispensing and label printing are not required to the drug dispensing device 7. That is, the control unit 201 outputs the preparation data to the mixing device 1 as the allocation result of step S7.
  • the mixing device 1 executes the mixing process based on the input preparation data, and dispenses an infusion container with the second label LA12 affixed thereto. Note that in this embodiment, an example is given of a case in which the output of the preparation data to the mixing device 1 serves as an instruction to execute the mixing process and an instruction to execute the recording process.
  • the control unit 201 may transmit a mixing instruction to the mixing device 1, which includes an instruction to execute the mixing process based on the preparation data and an instruction to record the recording process of the second label LA12 for the preparation data.
  • the drug dispensing device 7 no drug container and no second label LA12 are placed in each divided area TR11 of the transport tray TR1 corresponding to each of the input preparation data, but an injection prescription is placed, and the transport tray TR1 is dispensed.
  • the control unit 201 outputs a first dispensing instruction together with the preparation data to the drug dispensing device 7, thereby not allowing the second recording unit 704 or the second recording unit 804 provided separately from the co-infusion device 1 to record the second information on the second label LA12.
  • the control unit 201 does not allow the drug dispensing device 7 to dispense the drug container.
  • the control unit 201 does not output the preparation data to the mixing device 1, but outputs a second dispensing instruction indicating that drug dispensing is required and label printing is not required to the drug dispensing device 7 and the preparation data, and outputs the preparation data to the mixing support device 8. That is, the control unit 201 outputs the second dispensing instruction or preparation data, etc. to the drug dispensing device 7 or the mixing support device 8 as step S7.
  • the second label LA12 is not placed on each of the divided areas TR11 of the transport tray TR1 corresponding to each of the input preparation data, but a drug container and an injection prescription are placed, and the transport tray TR1 is dispensed.
  • a mixing support process is executed to support the mixing process performed manually by the user based on the preparation data, and the second label LA12 is printed for the preparation data.
  • the output of preparation data to the mixing assistance device 8 serves as both an instruction to execute the mixing assistance process and an instruction to execute the recording process.
  • control unit 201 when the control unit 201 outputs preparation data to the mixing assistance device 8, the control unit 201 may also transmit a mixing instruction to the mixing assistance device 8, the mixing instruction including an instruction to execute the mixing assistance process based on the preparation data and an instruction to record the recording process of the second label LA12 for the preparation data.
  • the control unit 201 does not output the preparation data to the co-infusion device 1, but outputs a third dispensing instruction indicating that drug dispensing and label printing are not required and the preparation data to the drug dispensing device 7, and outputs the preparation data to the co-infusion support device 8. That is, the control unit 201 outputs the preparation data to the co-infusion support device 8 as the allocation result of step S7.
  • the drug dispensing device 7 the drug container and the second label LA12 are not placed in each of the divided areas TR11 of the transport tray TR1 corresponding to each of the input preparation data, but an injection prescription is placed, and the transport tray TR1 is dispensed.
  • a co-infusion support process is executed to support the co-infusion process performed manually by the user based on the preparation data, and the second label LA12 is printed for the preparation data.
  • the control unit 201 does not output the preparation data to the co-infusion device 1 and the co-infusion support device 8, but outputs a fourth dispensing instruction indicating that drug dispensing and label printing are required and the preparation data to the drug dispensing device 7. That is, the control unit 201 outputs the fourth dispensing instruction and preparation data to the drug dispensing device 7 as the allocation result of step S7.
  • the fourth dispensing instruction is an example of the recording instruction mentioned above.
  • a drug container, a second label LA12, and an injection prescription are placed in each of the divided areas TR11 of the transport tray TR1 corresponding to each of the input preparation data, and the transport tray TR1 is dispensed.
  • the control unit 201 does not output the preparation data to the co-infusion device 1 and the co-infusion support device 8, but outputs a fifth dispensing instruction indicating that label printing is required and drug dispensing is not required, and the preparation data to the drug dispensing device 7. That is, the control unit 201 outputs the fifth dispensing instruction and the preparation data to the drug dispensing device 7 as the allocation result of step S7.
  • the fifth dispensing instruction is an example of the recording instruction mentioned above.
  • step S10 the control unit 201 causes the printing unit 205 to print (output) a preset patient list and a summary table, etc., based on the preparation data to be executed, and returns the process to step S1.
  • the patient list and the summary table, etc. may be printed by the co-infusion device 1, the drug dispensing device 7, the co-infusion support device 8, etc.
  • the control unit 201 when outputting the patient list is an example of an output processing unit according to the present invention.
  • the patient list various information including the number of infusion containers corresponding to the preparation data in the same second group and either or both of the types of the infusion containers are listed.
  • the patient list prints information such as the execution time of the closing process of the preparation data, the date and time of drug administration based on the preparation data (administration date and administration time), patient identification information shown in the preparation data, the Rp number corresponding to the preparation data, the type and number of each drug container and infusion container, and the order number of the prescription data corresponding to the preparation data.
  • information of each patient is arranged according to a preset priority order based on the date or time of drug administration based on the preparation data.
  • control unit 201 may print the patient list for that group.
  • patient list is not limited to being output in units of the second group, but may be output in any other units such as units of the first group or units of the closing process.
  • the summary table lists the drug containers and infusion containers that the user must manually prepare for mixed injection processing based on preparation data within the same second group. For example, as shown in FIG. 30(B), the summary table prints information such as the execution time of closing processing for the preparation data, the date of drug administration based on the preparation data (administration date), the type and number of drug containers, and the type and number of infusion containers.
  • the control unit 140 executes a co-infusion control process (see FIG. 31) for executing a co-infusion process based on the preparation data.
  • Step S21> 31 in step S21, the control unit 140 determines whether preparation data has been received. If preparation data has been received (S21: Yes), the process proceeds to step S22, and the process waits in step S21 until preparation data is received (S21: No).
  • the preparation data received from the higher-level system 2 is stored in the storage unit 200. As described above, the preparation data is grouped based on predetermined group conditions, and the preparation data includes group identification information.
  • preparation data received from the higher-level system 2 may be issued as targets for mixing process execution. Note that, of the unprocessed preparation data received from the higher-level system 2 and stored in the storage unit 200, only issued data will be targets for mixing process execution, and unissued data will not be targets for mixing process execution until it is issued.
  • step S22 the control unit 140 determines the execution order of the mixed injection process for the group to which each of the unprocessed preparation data currently stored in the storage unit 200 belongs. Specifically, when the preparation data is grouped by administration time, the control unit 140 determines the execution order of the mixed injection process for each group so that the administration time of the group is arranged in ascending order.
  • the control unit 140 determines the execution order of the mixed injection process for each group so that the administration time is arranged in ascending order, and when there are multiple groups with the same administration time, the control unit 140 determines the execution order of the mixed injection process for each group in alphabetical order, alphabetical order, or number order for the ward or person in charge.
  • a priority order can be set for each group in the upper system 2, and the control unit 140 may determine the execution order of the mixed injection process for each group based on the priority order.
  • step S23 the control unit 140 determines the execution order of the mixed injection process based on the unprocessed preparation data currently stored in the storage unit 200 for each group. Specifically, the control unit 140 determines the execution order of the mixed injection process based on the preparation data within the same group based on the contents of one or more items set in advance, such as the order number, the patient name, the ward, the person in charge, or the drug name. For example, when the execution order of the mixed injection process is determined based on the order number, the execution order of the mixed injection process is determined so that the execution order of the preparation data with a smaller order number (earlier order) is earlier.
  • the execution order of the mixed injection process is determined based on the patient name
  • the execution order of the mixed injection process is determined so that the execution order of the preparation data is earlier in alphabetical order.
  • the higher-level system 2 can set a priority for each preparation data, and the control unit 140 may determine the execution order of the mixed injection process based on the preparation data within the group based on the priority.
  • the execution order of the preparation data within the same group may be determined by the higher-level system 2.
  • step S24 the control unit 140 selects the group with the earliest execution order as the group to be subjected to the mixed injection process, in accordance with the execution order of the mixed injection process for the groups determined in step S22.
  • step S25 the control unit 140 selects the preparation data that has the earliest execution order within the group to be executed as the preparation data to be subjected to the mixed injection process, in accordance with the execution order of the mixed injection process based on the preparation data determined in step S23.
  • step S26 the control unit 140 executes a mixed injection process based on the preparation data selected as the execution target in step S25. Note that the control unit 140 stores the preparation data for which the mixed injection process has been completed in the storage unit 200 as processed preparation data in association with the results of the mixed injection process and the results of the inspection.
  • step S27 the control unit 140 judges whether or not the mixed injection process based on one preparation data is completed. If the mixed injection process is completed (S27: Yes), the control unit 140 shifts the process to step S28, and keeps the process on standby in step S27 until the mixed injection process is completed (S27: No).
  • step S27 of this embodiment the control unit 140 determines that the mixed injection process is complete when the injection process in which the medicinal liquid is injected into the infusion container is completed.
  • the process can be continued regardless of the results of the inspection performed by the mixed injection device 1 after the injection process is completed, and it is also possible to start mixed injection processes based on other preparation data, so that mixed injection processes based on multiple preparation data can be performed efficiently.
  • the control unit 140 may determine that the mixed injection process is completed when either of the following conditions is met: the injection process in which the medicinal liquid is injected into the infusion container is completed, and a shortage of equipment necessary for executing the mixed injection process has occurred. This allows the process to proceed not only when the injection process is completed, but also when an equipment shortage has occurred, and it is also possible to start a mixed injection process based on other preparation data in which the equipment is not insufficient, so that the mixed injection process based on multiple preparation data can be performed efficiently.
  • the control unit 140 performs the mixed injection process based on the preparation data in group units. That is, when an equipment shortage occurs in the mixed injection process based on the preparation data to be executed, the control unit 140 performs a mixed injection process based on other preparation data belonging to the same group as the preparation data, but does not perform a mixed injection process based on other preparation data belonging to other groups until the mixed injection process based on all preparation data belonging to the group is normally completed. In addition, when a condition such as a user operation or the passage of a preset period of time is met, the control unit 140 may execute a mixed injection process based on other preparation data belonging to another group.
  • step S27 the control unit 140 may determine that the mixed injection process is complete when the injection process in which the medicinal liquid is injected into the infusion container is completed and the result of the inspection performed after the injection process is determined to be normal.Furthermore, as another embodiment, in step S27, the control unit 140 may determine that the mixed injection process is complete when any of the following conditions is met: the injection process in which the medicinal liquid is injected into the infusion container is completed and the result of the inspection performed after the injection process is determined to be normal, and a shortage of equipment necessary to perform the mixed injection process has occurred.
  • step S28 the control unit 140 judges whether the co-infusion process based on all the preparation data of the current execution target group has been completed. If the co-infusion process based on all the preparation data of the current execution target group has been completed (S28: Yes), the process proceeds to step S29. If the co-infusion process based on all the preparation data of the current execution target group has not been completed (S28: No), the process proceeds to step S25. As a result, in steps S25 to S28, the control unit 140 selects each of the preparation data as an execution target for the co-infusion process in order according to the execution order, and executes the co-infusion process based on each of the preparation data in order. In addition, when the co-infusion process based on all the preparation data of the current execution target group has been completed, the control unit 140 notifies the user by displaying the fact on the touch panel 80 of the co-infusion device 1 or the collation terminal 9, etc.
  • step S29 the control unit 140 judges whether or not there is any unprocessed preparation data of a group other than the group that was the execution target. If there is preparation data of another group (S29: Yes), the process proceeds to step S22. If there is no preparation data of another group (S29: No), the process ends the series of mixed injection control processes and returns to step S21.
  • steps S22 to S29 the control unit 140 selects the preparation data to be subjected to the mixed injection process in order of execution of each group in units of groups, and causes the mixed injection device 1 to execute the mixed injection process based on the preparation data in units of the groups. That is, in the mixed injection device 1, after the mixed injection process based on all the preparation data belonging to one group is completed, the mixed injection process based on the preparation data belonging to the next group is started.
  • step S51 the control unit 140 judges whether an event to cancel the co-infusion process in the co-infusion device 1 has occurred for any of the preparation data assigned by the upper system 2 as preparation data to be used for the co-infusion process in the co-infusion device 1. For example, the control unit 140 judges that an event to cancel the co-infusion process based on the preparation data in the co-infusion device 1 has occurred when an error occurs in the co-infusion process based on the preparation data in the co-infusion device 1 during the execution of the co-infusion process based on the preparation data, making it impossible to complete the co-infusion process normally.
  • control unit 140 may notify the user to inquire whether to cancel the co-infusion process based on the preparation data in the co-infusion device 1, and may judge that an event to cancel the co-infusion process based on the preparation data in the co-infusion device 1 has occurred in response to a user operation. In addition, the control unit 140 may judge that an event to cancel the co-infusion process based on the preparation data in the co-infusion device 1 has occurred when a specific user operation is performed to cancel the co-infusion process based on the preparation data in the co-infusion device 1 for the preparation data arbitrarily selected by the user operation.
  • step S51 the cancellation of the co-infusion process based on the preparation data in the co-infusion device 1 can occur either before or after the start of the co-infusion process based on the preparation data.
  • the process waits in step S51 until it is determined that an event that cancels the co-infusion process based on the preparation data in the co-infusion device 1 has occurred (S51: No), and when it is determined that an event that cancels the co-infusion process based on the preparation data in the co-infusion device 1 has occurred (S51: Yes), the process proceeds to step S52.
  • step S52 the control unit 140 cancels the co-infusion processing based on the preparation data in the co-infusion device 1 by deleting the preparation data for which it is determined in step S51 that an event canceling the co-infusion processing in the co-infusion device 1 has occurred from the unprocessed preparation data stored in the storage unit 200.
  • the control unit 140 may leave the preparation data for which it is determined in step S51 that an event canceling the allocation to the co-infusion device 1 has occurred in the storage unit 200 as a processing history without deleting it.
  • Step S53 the control unit 140 outputs cancellation data to the upper system 2 to notify the cancellation of the co-infusion process based on the cancellation of the preparation data determined in step S51 that an event to cancel the co-infusion process in the co-infusion device 1 has occurred, and returns the process to step S51.
  • the cancellation data includes identification information such as patient identification information, order number, and Rp number for identifying the preparation data for which the co-infusion process in the co-infusion device 1 has been canceled.
  • the transmission of cancellation data to the higher-level system 2 in step S53 may be performed each time the co-infusion process based on the preparation data in the co-infusion device 1 is canceled, but the control unit 140 may transmit cancellation data for one or more pieces of preparation data collectively to the higher-level system 2 as the execution target at a preset time or at a preset interval. Also, the transmission of cancellation data to the higher-level system 2 in step S53 is performed each time the co-infusion process based on the preparation data in the co-infusion device 1 is canceled, and in step S61 described below, which is executed by the higher-level system 2, one or more pieces of cancellation data received up to that point may be selected as the execution target at a preset time or at a preset interval.
  • Transfer control process of upper system 2 executes a transfer control process (see FIG. 33) for transferring the co-infusion process for the preparation data for which the co-infusion process in the co-infusion device 1 has been canceled to another method and executing the same.
  • the transfer control process is a process executed by the control unit 201 substantially in parallel with the data output process, etc.
  • the transfer control process may also be executed by the control unit 140 of the co-infusion device 1.
  • Step S61> the control unit 201 judges whether the cancellation data has been received from the co-infusion device 1 in step S61. If it is not judged that the cancellation data has been received (S61: No), the process waits in step S61, and if it is judged that the cancellation data has been received (S61: Yes), the process proceeds to step S62.
  • the co-infusion process based on the preparation data in the co-infusion device 1 may be cancelable by a user operation in the upper system 2. In this case, the control unit 201 also shifts the process to step S62 when an operation to cancel the co-infusion process based on the preparation data in the co-infusion device 1 is performed in the upper system 2 (S61: Yes).
  • step S62 the control unit 201 notifies the user by printing cancellation information indicating that the co-infusion process performed by the co-infusion device 1 based on the preparation data corresponding to the cancellation data on the third label LA13 (see FIG. 34) by the third recording unit 206.
  • This allows the user to easily understand that the co-infusion process performed by the co-infusion device 1 based on the preparation data corresponding to the cancellation data has been canceled, and that it is necessary to manually perform the preparation of drug containers and the co-infusion process based on the preparation data. For example, as shown in FIG.
  • the cancellation information printed on the third label LA13 includes a message that the co-infusion process based on the preparation data has been canceled by the co-infusion device 1, or a message that the preparation of drugs is necessary.
  • the control unit 201 may notify the user by transmitting the cancellation information to the collation terminal 9 in step S62 and displaying the cancellation information on the collation terminal 9.
  • the control unit 201 may transmit the cancellation information to the mixed injection support device 8 and notify the user of the cancellation information by displaying or printing the cancellation information on the mixed injection support device 8.
  • the cancellation information may include identification information such as patient identification information, order number, and Rp number for identifying the preparation data corresponding to the cancellation data.
  • the control unit 201 may print the second information (an example of record information) related to the preparation data corresponding to the cancellation data on the second label LA12 by the third recording unit 206.
  • the control unit 201 may print the second label LA12 following the third label LA13 printed in step S62.
  • the preparation data printed on the second label LA12 is the preparation data for which the co-infusion process in the co-infusion device 1 has been canceled, and that the user should manually prepare the drug containers and perform the co-infusion process for the preparation data.
  • step S63 the control unit 201 judges whether the drug container used in the mixed injection process based on the preparation data corresponding to the cancellation data can be dispensed from the drug dispensing device 7. For example, the control unit 201 acquires information on the type of drug container contained in the drug dispensing device 7 from the drug dispensing device 7, and judges whether the drug container can be dispensed from the drug dispensing device 7 based on the information. The control unit 201 may also inquire of the drug dispensing device 7 whether the drug container can be dispensed, and judge whether the drug container can be dispensed from the drug dispensing device 7 based on the response from the drug dispensing device 7.
  • step S63 if it is judged that the drug container cannot be dispensed from the drug dispensing device 7 (S63: No), the process proceeds to step S631, and if it is judged that the drug container can be dispensed from the drug dispensing device 7 (S63: Yes), the process proceeds to step S64.
  • step S631 the control unit 201 judges whether or not to use the mixed injection support device 8 in the mixed injection process based on the preparation data corresponding to the cancellation data. Specifically, the control unit 201 judges that the mixed injection support device 8 will be used in the mixed injection process based on the preparation data when the second group to which the preparation data belongs is preset as a group that uses the mixed injection support device 8. Here, if it is judged that the mixed injection support device 8 will not be used (S631: No), the process proceeds to step S632, and if it is judged that the mixed injection support device 8 will be used (S631: Yes), the process proceeds to step S633.
  • step S632 the control unit 201 outputs preparation data corresponding to the cancellation data to the medicine dispensing device 7 together with the fifth dispensing instruction, thereby causing the medicine dispensing device 7 to dispense the second label LA12 and the injection prescription to the transport tray TR1. Thereafter, the control unit 201 returns the process to step S61. Note that in each step of the transfer control process, when the control unit 201 transmits preparation data corresponding to the cancellation data to the medicine dispensing device 7 or the co-infusion support device 8, the control unit 201 may output cancellation target information indicating that the co-infusion process in the co-infusion device 1 has been canceled for the preparation data.
  • step S633 the control unit 201 outputs preparation data corresponding to the cancellation data together with the third dispensing instruction to the medicine dispensing device 7, thereby causing the medicine dispensing device 7 to dispense an injection prescription. After that, the control unit 201 returns the process to step S61.
  • Step S64 On the other hand, if it is determined that the drug container can be dispensed from the drug dispensing device 7 (S63: Yes), in the following step S64, the control unit 201 determines whether or not to use the mixed injection support device 8 in the mixed injection process based on the preparation data corresponding to the cancellation data, similar to the step S631. If it is determined that the mixed injection support device 8 is not to be used (S64: No), the process proceeds to step S641, and if it is determined that the mixed injection support device 8 is to be used (S64: Yes), the process proceeds to step S65.
  • step S641 the control unit 201 outputs preparation data corresponding to the cancellation data together with the fourth dispensing instruction to the medicine dispensing device 7, thereby causing the medicine dispensing device 7 to dispense a medicine container, a second label LA12, and an injection prescription. After that, the control unit 201 returns the process to step S61.
  • step S65 the control unit 201 outputs preparation data corresponding to the cancellation data together with the second dispensing instruction to the medicine dispensing device 7, thereby causing the medicine dispensing device 7 to dispense a medicine container and an injection prescription. After that, the control unit 201 returns the process to step S61.
  • step S66 the control unit 201 outputs preparation data corresponding to the cancellation data to the mixed injection support device 8, thereby causing the mixed injection support device 8 to execute a mixed injection support process for supporting the mixed injection process of the user performed based on the preparation data, and to print the second label LA12 for the preparation data. After that, the control unit 201 returns the process to step S61.
  • the control unit 201 outputs the second dispensing instruction to the drug dispensing device 7 together with the preparation data, thereby causing the second recording unit 704 or the second recording unit 804, etc., provided separately from the co-infusion device 1, to record the second information on the second label LA12.
  • the control unit 201 switches the co-infusion method of the co-infusion process based on the preparation data from "mechanical co-infusion” to another co-infusion method such as "manual co-infusion” and executes the same.
  • the control unit 201 may be configured such that after the co-infusion process based on the preparation data in the co-infusion device 1 has been canceled, the control unit 201 cannot reassign the preparation data to the co-infusion device 1, and does not cause the co-infusion device 1 to execute the co-infusion process based on the preparation data.
  • control unit 201 may be configured to be able to reallocate the preparation data to the co-infusion device 1 after the co-infusion process based on the preparation data in the co-infusion device 1 is canceled, and to cause the co-infusion device 1 to execute the co-infusion process based on the preparation data.
  • an example of the cancellation of the co-infusion process may include a user performing an operation to confirm the inspection result after the inspection result of the co-infusion process in the co-infusion device 1 becomes inappropriate.
  • the control unit 701 of the medicine dispensing device 7 executes a medicine dispensing process (see FIG. 35 ) in which the second label LA12, medicine container, injection prescription, etc. corresponding to each of the preparation data corresponding to the same transport tray TR1 are placed on the transport tray TR1 and dispensed based on the preparation data and the corresponding information input to the medicine dispensing device 7. Note that the order of placing the second label LA12, medicine container, injection prescription, etc.
  • the medicine dispensing device 7 is not limited to that described here, and may be placed on the transport tray TR1 in another order, such as the order of the medicine container, the second label LA12, and the injection prescription, or the order of the second label LA12, the injection prescription, and the medicine container.
  • step S71 the control unit 701 judges whether or not preparation data corresponding to the transport tray TR1 has been input based on the corresponding information. Specifically, in this embodiment, when a plurality of preparation data are assigned to a plurality of divided regions TR11 provided on the same transport tray TR1, the control unit 701 judges that the preparation data corresponding to the transport tray TR1 has been input when all of the plurality of preparation data have been input. Note that, when only one preparation data is assigned to the same transport tray TR1, the control unit 701 judges that the preparation data corresponding to the transport tray TR1 has been input when the one preparation data has been input.
  • step S71: No the process waits in step S71, and when it is judged that the preparation data has been input (S71: Yes), the process proceeds to step S72. Then, in the following steps S72 to S76, one or more preparation data corresponding to the same transport tray TR1 are each set as an execution target, and the second label LA12, the medicine container, the injection prescription, and the like are dispensed to the transport tray TR1.
  • step S72 the control unit 701 judges whether printing of the second label LA12 is necessary. Specifically, when the fourth dispensing instruction or the fifth dispensing instruction is input together with the preparation data, the control unit 701 judges that printing of the second label LA12 is necessary. Also, when the first dispensing instruction, the second dispensing instruction, or the third dispensing instruction is input together with the preparation data, the control unit 701 judges that printing of the second label LA12 is not necessary.
  • step S72: Yes the process proceeds to step S73
  • step S74 when it is judged that printing of the second label LA12 is not necessary.
  • step S73 the control unit 701 causes the second recording unit 704 to print the second information on the second label LA12 based on the input preparation data, and places the second label LA12 in the divided area TR11 of the transport tray TR1 associated with the preparation data.
  • step S73 is not executed, and the second label LA12 is not dispensed.
  • step S72 the control unit 701 judges whether or not the dispensing of the drug container is necessary. Specifically, the control unit 701 judges that the dispensing of the drug container is necessary when the second dispensing instruction or the third dispensing instruction is input together with the preparation data. In addition, the control unit 701 judges that the dispensing of the drug container is unnecessary when the first dispensing instruction, the fourth dispensing instruction, or the fifth dispensing instruction is input together with the preparation data.
  • step S74: Yes the process proceeds to step S75
  • step S74: No the process proceeds to step S76.
  • step S75 the control unit 701 places the drug container required for the mixed injection process based on the preparation data in the divided area TR11 of the transport tray TR1 associated with the preparation data.
  • step S74 if neither the second dispensing instruction nor the third dispensing instruction has been input (S74: No), the step S75 is not executed and the drug container is not dispensed.
  • step S76 the control unit 701 prints the injection prescription based on the preparation data and places it on the transport tray TR1 associated with the preparation data. That is, in the present embodiment, the medicine dispensing device 7 switches between printing the second label LA12 and dispensing the medicine container depending on the situation, but the injection prescription is always printed and placed on the transport tray TR1. On the other hand, when the mixed injection process based on the preparation data in the mixed injection device 1 is canceled, the preparation data has already been input to the medicine dispensing device 7, and the injection prescription and transport tray TR1 corresponding to the preparation data may have been dispensed in the medicine dispensing device 7.
  • the control unit 701 when the control unit 701 receives the same preparation data as the already received preparation data, the injection prescription corresponding to the preparation data is not printed, and the medicine container or the second label LA12, etc. may be placed on a temporary tray for temporarily dispensing only medicines or a new transport tray TR1, etc., and dispensed.
  • the control unit 701 when receiving the cancellation information, may not print the injection prescription corresponding to the preparation data, but may place the medicine container or the second label LA12, etc. on the temporary tray or a new transport tray TR1, etc., and dispense the medicine.
  • the control unit 701 may place the medicine container or the second label LA12, etc. corresponding to the preparation data input by the transfer control process on the transport tray TR1 (division area TR11) and dispense the transport tray TR1.
  • the injection prescription corresponding to each of the preparation data has a size that can be placed on the division area TR11 of the transport tray TR1, the injection prescription corresponding to the preparation data is placed on the division area TR11 corresponding to the preparation data.
  • the injection prescription corresponding to each of the preparation data is of a size that can be placed in the divided area TR11 of the transport tray TR1
  • the injection prescription corresponding to the preparation data will be stacked and placed across multiple divided areas TR11 on the transport tray TR1 corresponding to that preparation data.
  • FIG. 36 is a diagram showing an example of the injection prescription corresponding to a case where the preparation method is the first preparation method, the co-injection process based on the preparation data corresponding to some of the multiple Rps included in one prescription data is performed by the co-injection device 1, and the co-injection process based on the preparation data corresponding to the other Rps is not performed by the co-injection device 1.
  • information such as the drug and infusion container is printed for each of one or more Rps included in the patient's prescription data in area A11 of the injection prescription.
  • information such as a figure or character indicating this is printed in area A12 of the injection prescription.
  • the control unit 701 may print information such as a figure or text indicating that the second label LA12 will not be placed on the transport tray TR1 on the injection prescription for preparation data in which the preparation method is the second preparation method.
  • the preparation method is the third preparation method and both the drug arrangement and the co-injection process are performed manually by the user
  • the drug container and the second label LA12 are not placed on the transport tray TR1 dispensed from the drug dispensing device 7.
  • the control unit 701 may print information such as a figure or text indicating that the drug container and the second label LA12 will not be placed on the transport tray TR1 on the injection prescription for preparation data in which the preparation method is the third preparation method. Furthermore, for preparation data in which the preparation method is the fifth preparation method and both the preparation of the medicines and the mixed injection process are performed manually by the user, the medicine container is not placed on the transport tray TR1 dispensed from the medicine dispensing device 7. Therefore, for preparation data in which the preparation method is the fifth preparation method, the control unit 701 may print information such as a figure or text indicating that the medicine container will not be placed on the transport tray TR1 on the injection prescription.
  • the multiple preparation data may be grouped into one cancellation group in the transfer control process, and the preparation data in the cancellation group may be collectively output to the drug dispensing device 7 and the mixed injection support device 8.
  • the control unit 201 may select multiple preparation data belonging to the cancellation group as one closing processing group, and execute the same process as step S8 and thereafter. As a result, the preparation data belonging to the cancellation group are assigned to the divided area TR11 of the same transport tray TR1.
  • the control unit 201 may print the summary table for the cancellation group by the printing unit 205. Note that the control unit 201 may print the summary table for each preparation data corresponding to the cancellation data individually.
  • step S77 the control unit 701 transports the transport tray TR1 on which the injection prescription and either or both of the second label LA12 and the medicine container are placed to a position where the user can take it out, and dispenses the transport tray TR1.
  • control unit 901 of the collation terminal 9 executes a medicine dispensing process (see FIG. 37) for collating the transport tray TR1 with the second label LA12 of the infusion container.
  • step S81 the control unit 901 displays on the display unit 904 information that prompts the user to read identification information, such as an order number and an Rp number, for identifying preparation data corresponding to the infusion container from code information printed on the second label LA12 attached to the infusion container, and reads the identification information by the code reading unit 903.
  • the control unit 901 may display on the display unit 904 tray identification information of the transport tray TR1 corresponding to the preparation data, etc., based on the correspondence information.
  • step S82 the control unit 901 displays on the display unit 904 information prompting the user to read the tray identification information of the transport tray TR1 from the code BC1 attached to the transport tray TR1, and causes the code reading unit 903 to read the tray identification information.
  • step S83 the control unit 901 executes a matching process to check whether or not the combination of the identification information of the preparation data read in step S81 and the tray identification information read in step S82 matches the combination associated in the correspondence information.
  • the control unit 901 when executing the process to determine whether or not the identification information of the preparation data read from the second label LA12 and the identification information of the transport tray TR1 read from the transport tray TR1 are associated by the correspondence processing unit is an example of a judgment processing unit according to the present invention.
  • step S84 if the result of the collation process in step S83 is a match (S84: Yes), the control unit 901 shifts the process to step S85. If the result of the collation process in step S83 is a mismatch (S84: No), the control unit 901 displays an error or the like on the display unit 904 and then returns the process to step S81.
  • step S85 the control unit 901 notifies the user of the position of the divided region TR11 in the transport tray TR1 where the infusion container should be placed. Specifically, the control unit 901 causes the display unit 904 to display the position of the divided region TR11 where the infusion container should be placed, based on the divided region identification information of the divided region TR11 associated with the combination of the preparation data identification information read in step S81 and the tray identification information read in step S82 in the correspondence information.
  • the control unit 901 when executing step S85 is an example of a notification processing unit according to the present invention.
  • the control unit 901 displays, on the display screen P2 of the display unit 904, patient identification information corresponding to the preparation data assigned to each divided region TR11 at the position of each divided region TR11 on the transport tray TR1.
  • the control unit 901 may display, on the display screen P2 of the display unit 904, patient identification information corresponding to the preparation data only at the position of the divided region TR11 on the transport tray TR1 to which the preparation data corresponding to the identification information read in step S81 is assigned. This allows the user to easily place infusion containers in each divided region TR11 of the transport tray TR1 by referring to the display screen P2.
  • step S85 when the code BC21 attached to the divided region TR11 is read by the code reading unit 903, the control unit 901 may determine whether the region identification information of the divided region TR11 corresponding to the code BC21 is associated with the preparation data corresponding to the identification information read in step S81 in the correspondence information.
  • the second label LA12 is printed by the second recording unit 704 or the second recording unit 804, which is provided separately from the co-infusion device 1. Therefore, even if the co-infusion process based on the preparation data in the co-infusion device 1 is canceled, the user can use the second label LA12 printed by the second recording unit 704 or the second recording unit 804, etc., and the user's work efficiency can be improved.
  • the control unit 201 of the upper system 2 has an equipment transfer function for transferring equipment that is necessary for the mixed injection process based on the preparation data but cannot be used in the mixed injection device 1 to another equipment.
  • an equipment transfer function for transferring equipment that is necessary for the mixed injection process based on the preparation data but cannot be used in the mixed injection device 1 to another equipment.
  • a special infusion container that does not require a syringe to inject a drug may be used because it has a function to inject a drug.
  • the special infusion container may not be able to be used in the mixed injection process due to mechanical limitations, etc.
  • the special infusion container is also generally called a saline solution kit.
  • the control unit 201 transfers the special infusion container to an infusion container and syringe that can be used with the mixing device 1.
  • the mixing process that cannot be performed with the mixing device 1 because it requires the special infusion container can be performed with the mixing device 1 by using the infusion container and syringe.
  • the control unit 201 of the upper system 2 has a prescription inspection function that performs a duplicate administration inspection process to determine whether or not a drug has been administered twice when there are multiple preparation data corresponding to the same patient, and an upper limit amount inspection process to determine whether or not the amount of drug exceeds the upper limit amount per day.
  • the control unit 201 determines that duplicate administration of a drug has occurred and notifies the user of the determination result.
  • the control unit 201 determines that duplicate administration of a drug has occurred even if the standard dosage amount, such as the dosage amount per body surface area, of the drug in each of the preparation data is different, and notifies the user of the determination result. In this way, even if the patient's body surface area differs due to differences in the issuance timing of each of the preparation data, for example, it is possible to notify the user of the occurrence of duplicate administration of a drug in the duplicate administration inspection process.
  • the control unit 201 of the upper system 2 determines that the upper limit amount has been exceeded if the total amount of the drug indicated in each of the preparation data exceeds the upper limit amount per day, and notifies the user of the determination result.
  • the control unit 201 determines that the upper limit amount has been exceeded if the total amount of the drug exceeds the upper limit amount per day, and notifies the user of the determination result. In this way, even if the patient's body surface area differs due to differences in the issuance timing of each of the preparation data, for example, it is possible to notify the user of the occurrence of the upper limit amount of the drug being exceeded in the upper limit amount inspection process.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Ce système d'injection mixte (100) est pourvu d'une unité de traitement de sélection (201) pour sélectionner un procédé de préparation de traitement par injection mixte sur la base de chacun de multiples éléments de données de préparation, une telle sélection étant effectuée sur la base : du moment de spécification auquel est exécuté le traitement de spécification pour spécifier un ou une pluralité des éléments de données de préparation qui servent de cible d'exécution d'un traitement par injection mixte dans lequel un médicament dans un récipient de médicament est injecté dans un récipient de perfusion ; et du moment auquel les médicaments correspondant à chacun des éléments de données de préparation sont utilisés.
PCT/JP2024/021646 2023-06-15 2024-06-14 Système et programme d'injection mixte Pending WO2024257850A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025528006A JPWO2024257850A1 (fr) 2023-06-15 2024-06-14

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023098801 2023-06-15
JP2023-098801 2023-06-15

Publications (1)

Publication Number Publication Date
WO2024257850A1 true WO2024257850A1 (fr) 2024-12-19

Family

ID=93852246

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2024/021646 Pending WO2024257850A1 (fr) 2023-06-15 2024-06-14 Système et programme d'injection mixte

Country Status (2)

Country Link
JP (1) JPWO2024257850A1 (fr)
WO (1) WO2024257850A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120284732A (zh) * 2025-06-13 2025-07-11 湖北聚瑞生物科技有限公司 一种润药装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019166302A (ja) * 2017-11-01 2019-10-03 株式会社湯山製作所 混注管理システム、混注管理プログラム、及び混注管理方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019166302A (ja) * 2017-11-01 2019-10-03 株式会社湯山製作所 混注管理システム、混注管理プログラム、及び混注管理方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120284732A (zh) * 2025-06-13 2025-07-11 湖北聚瑞生物科技有限公司 一种润药装置

Also Published As

Publication number Publication date
JPWO2024257850A1 (fr) 2024-12-19

Similar Documents

Publication Publication Date Title
JP6965974B2 (ja) 混注装置、混注方法、混注制御プログラム
JP6586419B2 (ja) 薬剤を調合するロボットシステム
KR100491632B1 (ko) 약제분류포장장치,약병및약제검사방법
US20120199239A1 (en) System for assisting medicinal liquid preparation and method for assisting medicinal liquid preparation
JP7235145B2 (ja) 混注装置、プログラム
JP7719484B2 (ja) 混注装置
JP7564485B2 (ja) 混注装置、混注方法、混注制御プログラム
WO2024257850A1 (fr) Système et programme d'injection mixte
JP7095260B2 (ja) 混注装置
JP6772706B2 (ja) 混注装置
WO2024225381A1 (fr) Système et programme d'injection mixte
JP7522378B2 (ja) 混注制御装置、混注制御プログラム、混注システム、混注装置
JP2025082197A (ja) 混注管理システム、読取端末、混注管理プログラム
WO2024135846A1 (fr) Appareil de commande de co-injection, système de co-injection et programme de commande de co-injection
JP7748005B2 (ja) 部材装着装置、制御プログラム
TW202333640A (zh) 混合注射裝置
JP2024002885A (ja) 混注装置
JP2025073881A (ja) 取出装置、保持装置、計量装置、及び、混注装置
WO2024225387A1 (fr) Dispositif d'agitation et dispositif d'injection mixte
JP2019033790A (ja) 混注制御装置、混注装置、混注制御プログラム
JP2025167755A (ja) 搬送装置、混注装置、及び、注入装置
JP2023159480A (ja) 部材装着装置、制御プログラム

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24823463

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2025528006

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2025528006

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE